Fenamates

RX_FENAMATES

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — M01AG 1 out of 7 registries used, show all original rules.	13484
4. Check minimum number of events Min. number of events 3	13484
5. Include endpoints None	13484
6. Filter based on genotype QC (FinnGen only)	13484

Control definitions (FinnGen only)

Control exclude: RX_NSAID

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_FENAMATES
CONTROL_EXCLUDE	RX_NSAID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	M01AG
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fenamates based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	13484	11477	2007
Unadjusted period prevalence (%)	3.46	3.91	0.88
Median age at first event (years)	38.45	37.14	45.98

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3208: Matched controls
29920

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M01AE03

ATC

ketoprofen; systemic, rectal

8.6

323.0

1131

1773

M01AE02

ATC

naproxen; oral, rectal

12.9

323.0

1916

3088

M01AB05

ATC

diclofenac; systemic, rectal

10.2

323.0

1899

3725

M01AH05

ATC

etoricoxib; oral

12.7

323.0

1500

1936

M03BX02

ATC

tizanidine; oral

7.7

323.0

1759

4047

M01AC06

ATC

meloxicam; systemic, rectal

12.0

323.0

871

902

N02AX02

ATC

tramadol; systemic, rectal

5.7

323.0

1299

3164

M01AE01

ATC

ibuprofen; systemic, rectal

6.9

323.0

2618

11695

M01AG02

ATC

tolfenamic acid; oral, rectal

1081.3

323.0

2911

259

M01AG01

ATC

mefenamic acid; oral

221.1

323.0

518

N02BE01

ATC

paracetamol; systemic, rectal

5.1

323.0

2592

13515

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

5.9

323.0

1362

3318

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

21.5

323.0

836

483

M03BC51

ATC

orphenadrine, combinations; systemic

7.9

317.4

816

1234

M02AA07

ATC

piroxicam; topical

5.9

309.3

1025

2190

M03BC01

ATC

orphenadrine (citrate); systemic

9.1

285.7

661

830

M01AX17

ATC

nimesulide; oral

10.5

279.4

592

633

M01AH01

ATC

celecoxib; oral (coxibs)

16.8

260.4

438

279

N02AJ06

ATC

codeine and paracetamol; systemic

4.9

259.9

1044

2695

J01AA02

ATC

doxycycline; systemic

3.7

258.7

2231

11331

M01AX05

ATC

glucosamine; oral

18.0

253.6

415

245

N03AX16

ATC

pregabalin; oral

6.7

242.8

693

1176

J01FA10

ATC

azithromycin; systemic

3.4

222.4

1673

7270

A02BC02

ATC

pantoprazole; systemic

3.3

213.8

1790

8329

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

16.9

213.5

357

220

N02CC03

ATC

zolmitriptan; nasal, oral

28.2

212.5

300

109

N02CC04

ATC

rizatriptan; oral

30.9

211.3

291

M54.5

ICD-10 Finland

Low back pain

4.3

198.7

873

2369

M01AH02

ATC

rofecoxib; oral

15.0

187.9

329

226

G43.9

ICD-10 Finland

Migraine, unspecified

16.7

186.4

312

191

A02BC05

ATC

esomeprazole; systemic

3.6

186.4

1071

3648

N02CC07

ATC

frovatriptan; oral

34.4

179.1

240

N03AX12

ATC

gabapentin; oral

7.9

178.5

444

599

R01AD09

ATC

mometasone; nasal

3.2

172.6

1205

4704

R01BA52

ATC

pseudoephedrine, combinations; oral

4.2

170.4

760

2054

R51.80

ICD-10 Finland

Headache

5.9

167.1

518

944

J01DA01

ATC

[U] cefalexin; systemic

2.8

165.8

1822

9514

G43

ICD-10 Finland

Migraine

17.8

160.4

262

149

J01DB01

ATC

cefalexin; oral

2.9

159.9

2395

14991

R06AE07

ATC

cetirizine; oral

2.9

152.7

1244

5292

M79.6

ICD-10 Finland

Pain in limb

3.5

151.5

884

2964

R03AC02

ATC

salbutamol; inhalant

2.8

151.1

1451

6839

N02CC05

ATC

almotriptan; oral

27.9

150.8

213

M25.5

ICD-10 Finland

Pain in joint

4.4

149.5

620

1544

N02CC06

ATC

eletriptan; oral

39.3

143.9

187

N06AX11

ATC

mirtazapine; oral

3.2

142.8

940

3424

C07AA05

ATC

propranolol; systemic

3.9

140.1

661

1845

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

9.1

136.2

306

344

J01FA09

ATC

clarithromycin; systemic

3.4

134.4

800

2688

R01AD08

ATC

fluticasone; nasal

3.3

134.1

807

2734

J01FA06

ATC

roxithromycin; oral

2.9

133.2

1074

4450

R05FB02

ATC

cough suppressants and expectorants

2.9

130.5

996

3972

M17.1

ICD-10 Finland

Other primary gonarthrosis

6.0

129.2

390

676

G44.2

ICD-10 Finland

Tension-type headache

5.9

125.8

383

670

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.8

125.3

467

1030

H02AB06

ATC

prednisolone; systemic

2.6

124.6

1254

5884

M01AC01

ATC

piroxicam; systemic, rectal

8.4

124.5

293

355

N05CF01

ATC

zopiclone; oral

2.9

123.4

949

3777

A02BC03

ATC

lansoprazole; oral

3.3

123.3

761

2605

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.3

123.3

318

444

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.8

123.0

1004

4149

N06AA09

ATC

amitriptyline; systemic

8.0

122.3

297

378

M01AB55

ATC

diclofenac, combinations; oral

22.6

120.7

181

M02AA10

ATC

ketoprofen; topical

5.4

119.5

392

749

J01CA04

ATC

amoxicillin; systemic

2.5

119.1

2358

15674

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.5

119.0

1360

6802

L03

ICPC

Low back symptom/complaint

3.6

117.9

624

1892

A03FA01

ATC

metoclopramide; systemic, rectal

3.6

117.4

625

1903

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

6.8

115.8

313

466

A02BC01

ATC

omeprazole; systemic

2.9

113.3

824

3136

J02AC01

ATC

fluconazole; systemic

2.8

112.8

878

3490

R05FA02

ATC

opium derivatives and expectorants; systemic

2.6

111.2

1050

4679

N05BA01

ATC

diazepam; systemic, rectal

4.1

109.1

481

1241

A02BA02

ATC

ranitidine; systemic

3.5

108.2

588

1809

N05BA04

ATC

oxazepam; oral

2.9

107.2

777

2933

M01AB01

ATC

indometacin; systemic, rectal

10.8

107.0

216

198

A06AC01

ATC

ispaghula (psylla seeds); oral

3.3

106.3

628

2056

M54.4

ICD-10 Finland

Lumbago with sciatica

5.5

106.0

339

625

R01AD12

ATC

fluticasone furoate; nasal

3.0

104.8

728

2669

C09CA06

ATC

candesartan; oral

3.2

104.4

649

2203

P01AB01

ATC

metronidazole; oral, rectal

2.6

102.3

945

4122

M48.0

ICD-10 Finland

Spinal stenosis

6.1

98.7

291

484

N05CF02

ATC

zolpidem; oral

4.0

98.1

441

1151

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.5

98.0

961

4314

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.2

95.7

570

1865

N89

ICPC

Migraine

13.0

95.5

176

133

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.8

94.9

731

2841

N06AX21

ATC

duloxetine; oral

6.0

94.5

280

468

R06AX27

ATC

desloratadine; oral

2.9

93.0

659

2426

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

6.9

88.5

236

342

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

88.0

522

1692

J01CE02

ATC

phenoxymethylpenicillin; oral

2.1

87.7

1930

12465

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.3

87.3

1135

5810

N03AX11

ATC

topiramate; oral

17.3

85.1

139

S01GX01

ATC

cromoglicic acid; ophthalmic

3.2

84.8

511

1674

N06AX16

ATC

venlafaxine; oral

3.8

84.6

399

1078

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

6.4

83.6

236

369

J01MA02

ATC

ciprofloxacin; systemic

2.3

83.5

1064

5369

M01AH03

ATC

valdecoxib; oral

16.8

83.0

137

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.2

82.9

342

819

J01FF01

ATC

clindamycin; systemic

2.6

81.8

697

2847

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.2

80.8

492

1620

M54

ICD-10 Finland

Dorsalgia

4.8

80.0

289

605

M01AB08

ATC

etodolac; oral

12.8

79.4

147

112

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

10.6

79.0

160

147

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.4

76.9

826

3804

R06AX22

ATC

ebastine; oral

3.4

75.9

417

1268

G43.3

ICD-10 Finland

Complicated migraine

47.4

75.4

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.6

75.1

661

2734

N06AB04

ATC

citalopram; systemic

2.7

74.7

608

2404

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

5.5

74.5

235

422

L01

ICPC

Neck symptom/complaint

4.0

74.3

330

842

R03AK07

ATC

formoterol and budesonide; inhalant

3.1

71.9

457

1542

N05CD07

ATC

temazepam; oral

3.2

69.7

412

1319

A03CA02

ATC

clidinium and psycholeptics; oral

6.4

68.9

191

291

L15

ICPC

Knee symptom/complaint

3.2

68.5

407

1307

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

5.6

67.4

208

363

N05BA12

ATC

alprazolam; oral

4.0

67.1

295

744

D07AC13

ATC

mometasone; topical

2.3

66.0

731

3379

H02BX01

ATC

methylprednisolone, combinations; systemic

9.6

65.8

140

141

R06AX13

ATC

loratadine; oral

3.1

64.8

406

1351

G56.0

ICD-10 Finland

Carpal tunnel syndrome

4.9

64.7

225

450

M09AX01

ATC

hyaluronic acid; parenteral

12.6

64.7

120

R07.4

ICD-10 Finland

Chest pain, unspecified

2.4

64.5

646

2837

C07AB07

ATC

bisoprolol; oral

1.9

64.4

1347

8126

N06AB10

ATC

escitalopram; oral

2.6

64.0

551

2230

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

7.5

64.0

159

207

M79.1

ICD-10 Finland

Myalgia

3.8

62.8

287

748

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.2

62.5

259

618

L08

ICPC

Shoulder symptom/complaint

3.2

62.4

356

1107

M19.0

ICD-10 Finland

Primary arthrosis of other joints

6.8

62.1

165

237

G47.3

ICD-10 Finland

Sleep apnoea

2.7

61.7

495

1920

3007

Kela drug reimbursment

Erenumab and fremanezumab

206.0

61.6

R03DC03

ATC

montelukast; oral

3.2

60.9

358

1136

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.5

60.8

567

2389

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

60.5

471

1794

N01

ICPC

Headache

3.5

60.4

314

909

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

10.1

60.3

125

120

E0000UV

ATC

2.0

60.1

1029

5715

M16.1

ICD-10 Finland

Other primary coxarthrosis

4.7

60.0

216

448

J01DA06

ATC

[U] cefuroxime; systemic

3.0

59.8

386

1306

M01AX01

ATC

nabumetone; oral

15.7

58.1

R03BA05

ATC

fluticasone; inhalant

2.7

58.0

462

1781

H02AB07

ATC

prednisone; oral

3.0

57.5

374

1270

H02AB04

ATC

methylprednisolone; systemic

3.0

57.3

376

1284

J01DA09

ATC

[U] cefadroxil; inhalant, oral

2.2

57.3

671

3159

D07AB02

ATC

hydrocortisone butyrate; topical

2.2

57.3

722

3517

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.9

57.1

387

1349

F51.0

ICD-10 Finland

Nonorganic insomnia

3.2

56.6

325

1012

M53.1

ICD-10 Finland

Cervicobrachial syndrome

4.8

56.2

199

405

R03AC03

ATC

terbutaline; inhalant

2.9

56.2

375

1295

WX110

NOMESCO Finland

Local anesthesy

1.8

56.1

1827

12623

R4110

NOMESCO Finland

Physiotherapy

2.2

56.1

669

3173

R06AE09

ATC

levocetirizine; oral

3.0

55.8

354

1181

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

10.3

55.2

113

106

G43.8

ICD-10 Finland

Other migraine

26.6

55.1

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.5

54.9

502

2085

M70.6

ICD-10 Finland

Trochanteric bursitis

5.8

54.9

164

275

N02CC02

ATC

naratriptan; oral

34.3

54.2

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

23.5

53.9

N05AH04

ATC

quetiapine; oral

2.4

53.2

516

2208

N02CX04

ATC

51.5

53.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

52.8

1092

6430

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

52.6

471

1931

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

4.2

52.2

212

495

X59

ICD-10 Finland

Exposure to unspecified factor

2.6

52.0

438

1734

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.7

52.0

402

1514

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.6

52.0

252

688

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

4.3

51.9

205

466

ZXA05

NOMESCO Finland

Left side

2.2

50.8

581

2690

WX320

NOMESCO Finland

Spinalanesthesy

2.4

50.7

510

2218

D07AC01

ATC

betamethasone; topical

2.0

49.7

793

4224

R42

ICD-10 Finland

Dizziness and giddiness

2.3

49.5

544

2466

R51

ICD-10 Finland

Headache

5.6

49.1

151

262

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

49.0

646

3180

N06AB03

ATC

fluoxetine; oral

2.9

48.7

319

1083

L17

ICPC

Foot/toe symptom/complaint

2.2

48.3

551

2539

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

48.1

1147

7037

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

48.1

681

3452

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

7.6

47.8

117

149

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

5.8

47.6

141

234

R01AD01

ATC

beclometasone; nasal

2.8

47.5

340

1222

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

9.8

46.8

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.8

46.6

213

553

R03BA02

ATC

budesonide; inhalant

2.4

46.4

424

1750

R53

ICD-10 Finland

Malaise and fatigue

2.1

45.8

593

2886

N06AA10

ATC

nortriptyline; systemic

19.3

45.6

M54.3

ICD-10 Finland

Sciatica

6.5

45.5

123

181

R06.0

ICD-10 Finland

Dyspnoea

2.1

45.2

595

2915

ZXA00

NOMESCO Finland

Right side

2.1

44.9

602

2971

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

16.0

44.5

M53.0

ICD-10 Finland

Cervicocranial syndrome

4.6

44.4

161

336

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.5

44.2

166

359

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

44.2

362

1404

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

44.2

1766

12561

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.6

44.2

369

1449

L02

ICPC

Back symptom/complaint

3.6

44.1

212

574

N94.4

ICD-10 Finland

Primary dysmenorrhoea

9.2

43.9

N02CD01

ATC

erenumab; parenteral

217.3

43.8

G04CA02

ATC

tamsulosin; oral

2.0

43.7

720

3855

G04CA01

ATC

alfuzosin; oral

2.6

43.2

356

1386

N02AC04

ATC

dextropropoxyphene; oral

6.6

43.0

115

167

J02AC02

ATC

itraconazole; systemic

2.6

42.9

345

1324

A07EC01

ATC

sulfasalazine; oral, rectal

5.1

42.9

141

265

E000001

ATC

2.1

42.8

552

2675

M54.2

ICD-10 Finland

Cervicalgia

5.0

42.7

145

282

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

12.1

42.3

J01AA07

ATC

tetracycline; systemic

2.4

42.3

392

1626

C05AA08

ATC

fluocortolone; rectal, topical

2.8

42.1

299

1067

R5140

NOMESCO Finland

Monitoring the use of the aid

3.0

41.9

255

823

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

8.1

41.8

114

L13

ICPC

Hip symptom/complaint

3.0

41.7

263

869

S18

ICPC

Laceration/cut

1.8

41.4

921

5457

J01MA06

ATC

norfloxacin; oral

2.7

41.4

301

1088

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

6.6

41.3

110

159

N06AA12

ATC

doxepin; systemic

4.5

40.9

154

334

R74

ICPC

Upper respiratory infection acute

1.9

40.6

687

3702

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

8.1

40.4

111

N02AA05

ATC

oxycodone; systemic

2.4

40.1

371

1535

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

40.0

1260

8285

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

6.5

40.0

108

159

X58

ICD-10 Finland

Exposure to other specified factors

2.7

39.8

305

1136

R52.9

ICD-10 Finland

Pain, unspecified

3.7

39.8

183

477

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.6

39.8

191

516

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.1

39.8

113

178

J35.0

ICD-10 Finland

Chronic tonsillitis

4.5

39.6

149

323

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

4.4

39.4

150

329

N06AB06

ATC

sertraline; oral

2.7

39.2

298

1104

ACC51

NOMESCO Finland

Release of median nerve

6.0

39.2

112

178

G04BD12

ATC

mirabegron; oral

3.2

38.9

225

698

M77.1

ICD-10 Finland

Lateral epicondylitis

6.2

38.4

108

168

R01AD11

ATC

triamcinolone; nasal

3.4

38.3

199

572

A01AB09

ATC

miconazole; local oral

3.1

38.2

221

686

WX002

NOMESCO Finland

Sedation and analgesia

2.2

38.1

459

2151

R03BA01

ATC

beclometasone; inhalant

2.5

37.6

326

1301

H04.10

ICD-10 Finland

Dry eye syndrome

3.4

37.6

194

555

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

12.9

37.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

37.5

505

2482

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.8

37.3

889

5353

K30

ICD-10 Finland

Functional dyspepsia

3.1

37.3

216

672

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

7.0

37.1

130

A03FA02

ATC

cisapride; oral, rectal

3.3

36.9

198

583

A07DA03

ATC

loperamide; oral

5.2

36.7

119

220

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.8

36.7

251

871

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

36.7

241

817

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.5

36.6

310

1219

M03AX01

ATC

botulinum toxin; parenteral

23.9

36.6

B01AB05

ATC

enoxaparin; parenteral

1.9

36.4

641

3487

J01FA15

ATC

telithromycin; oral

3.4

36.2

187

535

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

24.6

36.2

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

4.2

36.1

143

326

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.9

36.1

158

395

N02CD03

ATC

fremanezumab; systemic

346.4

36.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

35.8

975

6097

M01AB16

ATC

aceclofenac; oral

29.0

35.7

J01MA12

ATC

levofloxacin; systemic

2.1

35.6

451

2154

UJF32

NOMESCO Finland

Coloscopy

1.9

35.3

585

3105

ZXA10

NOMESCO Finland

Bilateral

2.1

34.8

430

2032

M01AE51

ATC

ibuprofen, combinations; systemic

29.6

34.4

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

6.4

34.4

141

R35

ICD-10 Finland

Polyuria

3.4

34.2

173

487

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

34.2

613

3346

A06AD11

ATC

lactulose; oral

2.1

34.1

416

1955

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

11.4

34.0

R07.3

ICD-10 Finland

Other chest pain

3.0

33.8

208

673

J45

ICD-10 Finland

Asthma

3.0

33.8

208

673

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

33.7

205

660

L28

ICPC

Limited function/disability (L)

2.2

33.7

379

1716

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.9

33.7

222

753

M01AE11

ATC

tiaprofenic acid; oral, rectal

10.3

33.7

R52.2

ICD-10 Finland

Other chronic pain

8.4

33.6

J01FA01

ATC

erythromycin; systemic

2.2

33.6

385

1758

EMB10

NOMESCO Finland

Tonsillectomy

3.8

33.5

148

373

D07AA02

ATC

hydrocortisone; topical

2.2

33.3

363

1622

M01AC02

ATC

tenoxicam; systemic, rectal

8.1

33.2

J01EA01

ATC

trimethoprim; systemic

1.9

33.2

588

3192

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

33.1

390

1803

N80.9

ICD-10 Finland

Endometriosis, unspecified

11.5

33.1

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

27.2

33.0

D07CC01

ATC

betamethasone and antibiotics; topical

2.4

32.9

295

1194

R05

ICD-10 Finland

Cough

2.2

32.8

377

1720

R01BA51

ATC

phenylpropanolamine, combinations; oral

2.3

32.7

321

1362

A02BC04

ATC

rabeprazole; oral

3.7

32.7

152

400

N03AE01

ATC

clonazepam; systemic

3.8

32.6

147

377

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.9

32.5

561

3012

S83.2

ICD-10 Finland

Tear of meniscus, current

4.2

32.5

128

291

A01

ICPC

Pain general/multiple sites

3.3

32.4

173

508

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.2

32.3

354

1584

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

10.3

32.3

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

32.3

474

2400

P01BA02

ATC

hydroxychloroquine; oral

4.9

31.9

108

210

E66.01

ICD-10 Finland

Obesity due to excess calories

3.2

31.3

173

521

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.8

31.3

220

777

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

31.2

475

2434

J34.2

ICD-10 Finland

Deviated nasal septum

3.9

31.0

133

327

F45.8

ICD-10 Finland

Other somatoform disorders

3.3

31.0

168

499

R05DA01

ATC

ethylmorphine; oral

3.2

30.8

171

517

D01

ICPC

Abdominal pain/cramps general

2.5

30.8

257

1003

R01AD05

ATC

budesonide; nasal

3.2

30.7

174

533

J01AA04

ATC

lymecycline; systemic

2.2

30.6

331

1471

M23.8

ICD-10 Finland

Other internal derangements of knee

7.9

30.4

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

30.4

636

3637

J01MA01

ATC

ofloxacin; systemic

2.8

30.3

208

725

N06AX12

ATC

bupropion; oral

3.2

30.2

170

517

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.7

29.8

815

5052

R05

ICPC

Cough

1.9

29.8

469

2432

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.4

29.7

262

1052

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

29.5

318

1409

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

29.2

367

1741

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

29.1

690

4098

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

29.0

254

1015

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.4

28.9

270

1115

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.7

28.9

101

204

P06

ICPC

Sleep disturbance

2.6

28.8

227

857

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

7.4

28.7

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

28.3

1269

8895

A06AC51

ATC

ispaghula, combinations; systemic

4.1

28.3

114

265

J01CA08

ATC

pivmecillinam; oral

1.7

28.3

807

5048

M01AE52

ATC

naproxen and esomeprazole; oral

15.3

28.1

M47.82

ICD-10 Finland

Other spondylosis, cervical region

8.1

27.8

J20

ICD-10 Finland

Acute bronchitis

2.9

27.8

177

588

R01BA01

ATC

phenylpropanolamine; oral

4.3

27.8

106

234

J01DC02

ATC

cefuroxime; systemic

3.7

27.8

128

335

K02.1

ICD-10 Finland

Caries of dentine

1.5

27.3

1420

10276

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.0

27.2

112

266

A04

ICPC

Weakness/tiredness general

2.0

27.1

369

1804

SPAT1283

SPAT

Restricted health certificate

1.9

27.0

451

2383

AA1AD

NOMESCO Finland

CT of head and brain

1.8

27.0

587

3385

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

4.4

26.9

101

220

N06AX26

ATC

vortioxetine; oral

3.2

26.8

151

460

G44.0

ICD-10 Finland

Cluster headache syndrome

16.9

26.7

D01BA02

ATC

terbinafine; oral; topical

1.8

26.7

523

2916

L16

ICPC

Ankle symptom/complaint

2.7

26.7

193

693

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

4.3

26.6

101

222

J01DA08

ATC

[U] cefaclor; oral

2.1

26.6

338

1608

K07.60

ICD-10 Finland

Snapping jaw

4.2

26.5

103

232

M01AB51

ATC

indometacin, combinations; oral, rectal

14.6

26.5

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.9

26.5

168

557

M54.6

ICD-10 Finland

Pain in thoracic spine

3.8

26.4

115

287

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.0

26.4

158

504

N03AX09

ATC

lamotrigine; oral

3.2

26.3

144

431

R06.5

ICD-10 Finland

Mouth breathing

2.8

26.3

183

641

N05AB04

ATC

prochlorperazine; systemic, rectal

5.7

26.2

128

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

6.4

26.0

104

WX290

NOMESCO Finland

Other blockade of nerve

1.5

25.7

1057

7222

J05AB01

ATC

aciclovir; systemic

1.9

25.6

406

2103

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

10.7

25.6

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

4.6

25.6

192

N06AB05

ATC

paroxetine; oral

3.2

25.6

142

430

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.9

25.6

163

542

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

11.0

25.4

L12

ICPC

Hand/finger symptom/complaint

2.2

25.3

262

1137

M22.4

ICD-10 Finland

Chondromalacia patellae

7.7

25.3

L11

ICPC

Wrist symptom/complaint

3.0

25.3

156

507

R06AX26

ATC

fexofenadine; oral

3.3

25.3

132

382

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

3.4

25.3

127

357

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.7

25.1

176

621

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

25.0

1298

9324

A02BA04

ATC

nizatidine; systemic

2.7

25.0

175

615

N05CD08

ATC

midazolam; nasal, systemic

5.6

25.0

128

B02AA02

ATC

tranexamic acid; systemic

2.5

24.9

202

773

R06AX12

ATC

terfenadine; oral

3.5

24.9

122

336

UKC02

NOMESCO Finland

Cystoscopy

1.9

24.6

408

2148

D01AC03

ATC

econazole; topical

3.1

24.5

143

448

A98

ICPC

Health maint/preventive medicine

1.7

24.5

2749

23344

NF1AA

NOMESCO Finland

Hip X-ray examination

2.8

24.5

165

568

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.5

24.5

188

J31.0

ICD-10 Finland

Chronic rhinitis

3.0

24.4

146

465

J01

ICD-10 Finland

Acute sinusitis

4.1

24.4

228

C01CA24

ATC

epinephrine; parenteral

3.2

24.3

133

399

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

24.3

731

4610

M15

ICD-10 Finland

Polyarthrosis

6.1

24.1

104

A02BX02

ATC

sucralfate; oral

3.7

24.0

110

287

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

9.8

24.0

D11

ICPC

Diarrhoea

2.2

23.9

257

1134

D07AD01

ATC

clobetasol; topical

2.2

23.9

273

1238

M79.7

ICD-10 Finland

Fibromyalgia

22.0

23.8

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

23.8

120

339

R03BA08

ATC

ciclesonide; inhalant

2.9

23.6

147

481

L86

ICPC

Back syndrome with radiating pain

4.5

23.5

183

K08.80

ICD-10 Finland

Toothache NOS

2.9

23.4

149

495

G04BD08

ATC

solifenacin; oral

3.0

23.2

138

437

N05CD02

ATC

nitrazepam; oral

5.3

23.2

128

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

23.2

393

2079

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.2

23.2

126

376

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

23.1

586

3520

OAA65

SPAT

2.6

23.0

179

672

M76.6

ICD-10 Finland

Achilles tendinitis

4.8

22.9

154

M45

ICD-10 Finland

Ankylosing spondylitis

11.6

22.9

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

17.8

22.9

S06.0

ICD-10 Finland

Concussion

2.2

22.9

252

1124

L84

ICPC

Back syndrome without radiat pain

4.1

22.9

210

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

2.0

22.8

313

1530

R02

ICPC

Shortness of breath/dyspnoea

2.1

22.8

261

1186

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.3

22.8

119

345

N30.0

ICD-10 Finland

Acute cystitis

2.0

22.7

319

1576

M54.1

ICD-10 Finland

Radiculopathy

5.9

22.7

105

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

22.7

111

306

S80.0

ICD-10 Finland

Contusion of knee

3.1

22.6

128

393

D01AE16

ATC

amorolfine; topical

2.2

22.5

233

1010

D01AC02

ATC

miconazole; topical

2.4

22.4

198

793

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

7.4

22.4

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

22.3

333

1681

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

22.3

1333

9787

M47.9

ICD-10 Finland

Spondylosis, unspecified

6.6

22.2

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

5.5

22.1

116

N80

ICD-10 Finland

Endometriosis

17.3

22.1

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

22.0

434

2416

N17

ICPC

Vertigo/dizziness

2.2

22.0

241

1074

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

21.9

132

424

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

8.0

21.8

N03AF01

ATC

carbamazepine; oral, rectal

2.9

21.8

135

440

M79.0

ICD-10 Finland

Rheumatism, unspecified

10.4

21.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

21.7

199

812

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

5.4

21.7

115

M75

ICD-10 Finland

Shoulder lesions

4.9

21.7

139

S29

ICPC

Skin symptom/complaint other

1.8

21.6

373

1986

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

21.5

609

3759

DJD20

NOMESCO Finland

Plastic repair of septum of nose

4.2

21.5

191

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

21.5

244

1103

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

4.4

21.4

174

C05AA01

ATC

hydrocortisone; rectal, topical

3.4

21.4

107

301

E66.8

ICD-10 Finland

Other obesity

3.7

21.3

243

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

21.3

368

1958

F32

ICD-10 Finland

Depressive episode

2.9

21.2

133

438

D06

ICPC

Abdominal pain localized other

2.5

21.2

171

655

R03BC03

ATC

nedocromil; inhalant

3.0

21.2

126

399

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.0

21.2

281

1356

Z71.8

ICD-10 Finland

Other specified counselling

1.6

21.1

563

3422

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

7.7

20.9

L29

ICPC

Musculoskeletal sympt/complt other

2.8

20.9

143

497

N06AA06

ATC

trimipramine; systemic

5.5

20.9

109

M75.8

ICD-10 Finland

Other shoulder lesions

5.3

20.8

117

M35.7

ICD-10 Finland

Hypermobility syndrome

17.2

20.8

TLC00

NOMESCO Finland

Insertion of intrauterine device

3.7

20.8

244

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

20.7

219

960

A11

ICPC

Chest pain NOS

2.6

20.6

153

559

M05BA04

ATC

alendronic acid; oral

2.5

20.5

168

648

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

21.7

20.4

P01

ICPC

Feeling anxious/nervous/tense

1.9

20.2

303

1530

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

3.5

20.2

255

C07AB02

ATC

metoprolol; systemic

1.6

20.1

553

3382

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

20.1

131

442

Z01.2

ICD-10 Finland

Dental examination

1.5

20.1

894

6136

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.6

20.0

147

N06AG02

ATC

moclobemide; oral

3.4

19.9

101

287

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

4.5

19.9

148

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.8

19.9

133

455

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.2

19.9

212

930

H01

ICPC

Ear pain/earache

2.1

19.9

224

1009

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

6.7

19.8

D07AB08

ATC

desonide; topical

2.1

19.8

245

1148

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

19.8

132

451

N03AG01

ATC

valproic acid; systemic, rectal

2.3

19.8

186

769

N07CA01

ATC

betahistine; oral

2.6

19.7

148

544

TQW40

NOMESCO Finland

Remowal of suture of skin

2.7

19.7

141

505

XQ800

NOMESCO Finland

Prick test

2.7

19.7

143

514

A99

ICPC

Disease/condition unspecnature/site

2.3

19.6

189

793

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

19.6

786

5272

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

19.5

565

3501

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

19.4

134

469

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

19.3

183

761

N04BC05

ATC

pramipexole; oral

2.9

19.3

123

411

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

19.2

1564

12055

F34.1

ICD-10 Finland

Dysthymia

3.5

19.2

256

G44.8

ICD-10 Finland

Other specified headache syndromes

12.8

19.1

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.8

19.1

387

2165

H03AA01

ATC

levothyroxine sodium; systemic

1.7

19.0

411

2345

N06AX05

ATC

trazodone; oral

4.6

19.0

138

N41.1

ICD-10 Finland

Chronic prostatitis

5.3

19.0

106

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

19.0

140

510

E000002

ATC

2.0

18.9

264

1300

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

18.8

249

1200

R05DB20

ATC

other cough suppressants - combinations

2.6

18.7

145

543

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.8

18.6

123

420

M04AA01

ATC

allopurinol; systemic

1.9

18.6

271

1355

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

4.8

18.6

121

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.8

18.4

125

434

N30

ICD-10 Finland

Cystitis

2.4

18.4

159

633

SPAT1216

SPAT

Assessment of functional ability

1.8

18.4

337

1828

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.7

18.4

377

2117

KMAK

NOMESCO Finland

1.4

18.4

1242

9228

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

18.3

177

743

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.8

18.3

120

407

S01AA01

ATC

chloramphenicol; ophthalmic (antibiotics)

2.7

18.3

129

459

R07.0

ICD-10 Finland

Pain in throat

2.7

18.2

124

431

K04.0

ICD-10 Finland

Pulpitis

2.2

18.2

201

899

R09

ICPC

Sinus symptom/complaint

2.5

18.2

148

570

R96

ICPC

Asthma

2.3

18.2

168

691

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

18.1

163

662

A01AB04

ATC

amphotericin B; local oral

3.0

18.1

106

335

N06AX03

ATC

mianserin; oral

3.1

18.1

104

324

M77.4

ICD-10 Finland

Metatarsalgia

3.9

18.1

186

R51.81

ICD-10 Finland

Facial pain NOS

7.0

18.1

R21

ICPC

Throat symptom/complaint

1.7

18.0

453

2698

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.8

18.0

196

N02AJ13

ATC

tramadol and paracetamol; systemic

10.0

18.0

SPAT1263

SPAT

Sampling

1.4

18.0

1055

7624

Z50.1

ICD-10 Finland

Other physical therapy

2.9

18.0

113

373

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

6.3

17.9

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.6

17.9

211

OAB43

SPAT

1.8

17.9

331

1800

N05BA02

ATC

chlordiazepoxide; systemic

4.1

17.9

165

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

6.8

17.9

H02.3

ICD-10 Finland

Blepharochalasis

3.2

17.8

276

C08DA01

ATC

verapamil; systemic

2.8

17.8

117

397

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

17.8

212

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

17.8

367

2061

J05AB11

ATC

valaciclovir; oral

2.0

17.8

235

1133

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.2

17.6

194

863

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

8.0

17.6

G43.2

ICD-10 Finland

Status migrainosus

41.2

17.6

R03AC13

ATC

formoterol; inhalant

2.9

17.6

108

352

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

17.5

171

721

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.9

17.5

110

363

SPAT1254

SPAT

Administration of medicine

1.7

17.5

382

2187

SPAT1325

SPAT

Vaccination

1.5

17.5

822

5682

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.0

17.4

L10

ICPC

Elbow symptom/complaint

3.4

17.4

236

G04BD04

ATC

oxybutynin; oral, transdermal

2.7

17.4

120

422

N07BA03

ATC

varenicline; oral

3.2

17.3

282

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.7

17.3

118

C08CA01

ATC

amlodipine; oral

1.5

17.3

805

5545

XF402

NOMESCO Finland

ECG with work load test

2.0

17.2

235

1147

L90

ICPC

Osteoarthrosis of knee

4.0

17.1

159

A07AA02

ATC

nystatin; oral

2.6

17.0

128

473

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.3

16.9

158

654

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.9

16.9

271

1403

N05BB01

ATC

hydroxyzine; systemic

2.4

16.9

152

618

N05CD05

ATC

triazolam; oral, sublingual

6.1

16.9

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

3.0

16.8

304

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

16.7

300

1613

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

16.7

246

1236

M13.9

ICD-10 Finland

Arthritis, unspecified

2.8

16.6

106

355

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

6.7

16.5

M19.9

ICD-10 Finland

Arthrosis, unspecified

5.2

16.5

J01MA14

ATC

moxifloxacin; systemic

2.1

16.5

182

815

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

4.4

16.5

129

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

5.8

16.5

C09CA01

ATC

losartan; oral

1.6

16.4

487

3024

N06BA04

ATC

methylphenidate; oral

4.1

16.4

147

SPAT1240

SPAT

Therapeutic discussion

1.8

16.4

293

1573

M43.1

ICD-10 Finland

Spondylolisthesis

5.3

16.3

P03

ICPC

Feeling depressed

1.9

16.3

241

1209

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

14.9

16.3

D07XC01

ATC

betamethasone, combinations; topical

2.0

16.2

229

1131

SPAT1153

SPAT

Removal of sutures

1.5

16.2

606

3974

355

Kela drug reimbursment

Dienogest

59.3

16.2

L14

ICPC

Leg/thigh symptom/complaint

2.4

16.2

138

545

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.3

16.1

132

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

16.1

338

1909

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

16.1

479

2981

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

6.7

16.1

L88

ICPC

Rheumatoid/seropositive arthritis

5.2

16.0

R06.2

ICD-10 Finland

Wheezing

3.0

16.0

293

A03

ICPC

Fever

1.7

16.0

357

2052

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

3.8

15.9

174

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

15.8

821

5766

DHB50

NOMESCO Finland

Turbinoplasty

5.5

15.8

H92.0

ICD-10 Finland

Otalgia

3.0

15.8

285

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.2

15.8

165

720

N05BE01

ATC

buspirone; oral

3.3

15.8

224

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

3.5

15.7

195

F29

ICPC

Eye symptom/complaint other

2.2

15.7

165

722

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.0

15.7

207

996

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.7

15.7

172

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

15.6

991

7222

A03DA02

ATC

pitofenone and analgesics; systemic

5.0

15.6

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.9

15.6

154

H29

ICPC

Ear symptom/complaint other

2.0

15.6

200

953

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.5

15.6

126

485

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

15.6

116

427

C10AA07

ATC

rosuvastatin; oral

1.6

15.5

419

2539

SPAT1310

SPAT

Counselling related to known health issue

1.5

15.5

739

5102

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.1

15.4

273

M54.8

ICD-10 Finland

Other dorsalgia

3.7

15.4

170

R50.9

ICD-10 Finland

Fever, unspecified

1.7

15.4

325

1838

E66.9

ICD-10 Finland

Obesity, unspecified

3.5

15.4

199

R60.0

ICD-10 Finland

Localized oedema

2.0

15.4

212

1038

H66.9

ICD-10 Finland

Otitis media, unspecified

2.5

15.3

118

442

R10.2

ICD-10 Finland

Pelvic and perineal pain

4.9

15.3

Z30.2

ICD-10 Finland

Sterilization

2.7

15.3

110

395

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

8.2

15.3

G04BD11

ATC

fesoterodine; oral

4.4

15.3

117

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.0

15.3

201

964

L20

ICPC

Joint symptom/complaint NOS

4.2

15.3

130

E66

ICD-10 Finland

Obesity

3.3

15.3

220

X02

ICPC

Menstrual pain

3.1

15.2

256

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

15.2

494

3135

L05

ICPC

Flank/axilla symptom/complaint

2.7

15.1

103

360

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.6

15.1

114

423

L60.0

ICD-10 Finland

Ingrowing nail

3.0

15.0

285

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

15.0

870

6227

B01AX06

ATC

[U] rivaroxaban; oral

10.5

15.0

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.5

14.9

189

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.3

14.9

138

567

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

14.9

308

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

9.7

14.9

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.4

14.9

124

485

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.7

14.9

104

369

D06BB03

ATC

aciclovir; topical

3.2

14.9

235

34609

ICD-8 Finland

Migraine, Unspecified

12.8

14.8

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

4.4

14.8

117

H01.0

ICD-10 Finland

Blepharitis

2.6

14.8

111

411

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.0

14.8

193

926

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

2.5

14.7

118

453

G04BD07

ATC

tolterodine; oral

2.7

14.6

100

351

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

14.6

346

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.5

14.5

116

444

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.9

14.5

146

M75.5

ICD-10 Finland

Bursitis of shoulder

7.2

14.5

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.4

14.5

111

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

14.5

334

1937

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.2

14.4

155

683

R03CC02

ATC

salbutamol; systemic

2.1

14.4

165

751

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

14.4

233

1208

WX402

NOMESCO Finland

General anaesthesia

1.7

14.4

319

1830

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.1

14.4

162

732

A02BA03

ATC

famotidine; systemic

2.9

14.3

294

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.1

14.3

242

C10AA05

ATC

atorvastatin; oral

1.4

14.3

798

5665

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

14.3

135

564

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

14.3

365

2179

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

4.4

14.2

109

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

8.8

14.2

R11

ICD-10 Finland

Nausea and vomiting

2.0

14.2

184

879

M03BX01

ATC

baclofen; systemic

5.6

14.2

U02

ICPC

Urinary frequency/urgency

1.8

14.1

240

1266

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.3

14.0

115

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

14.0

356

2123

R05DB05

ATC

pentoxyverine; oral, rectal

3.4

13.9

190

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.8

13.9

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

6.7

13.9

L04AA13

ATC

leflunomide; oral

11.1

13.9

K10.3

ICD-10 Finland

Alveolitis of jaws

3.3

13.9

196

S22.3

ICD-10 Finland

Fracture of rib

2.3

13.8

126

516

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

13.8

108

408

JAH01

NOMESCO Finland

Laparoscopy

3.0

13.7

248

S01KA02

ATC

hypromellose; ophthalmic

6.6

13.7

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

13.7

295

1679

D01AE15

ATC

terbinafine; topical

2.2

13.7

141

613

R06AX18

ATC

acrivastine; oral

4.0

13.7

131

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.5

13.6

104

389

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

13.6

635

4349

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.8

13.6

310

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

7.0

13.6

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.5

13.6

XKD00

NOMESCO Finland

Uroflowmetry

1.6

13.6

401

2483

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

13.5

686

4774

N06AB08

ATC

fluvoxamine; oral

3.8

13.5

142

K04.00

ICD-10 Finland

Hyperemia of pulp

2.7

13.5

329

R13

ICD-10 Finland

Dysphagia

2.3

13.4

124

513

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.2

13.4

133

566

R05DA09

ATC

dextromethorphan; oral

6.3

13.4

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

3.5

13.3

168

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

2.3

13.2

120

492

C07AB12

ATC

nebivolol; oral

3.6

13.2

159

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

13.2

201

1024

R01AC02

ATC

levocabastine; nasal

3.3

13.2

189

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

7.0

13.1

TLC02

NOMESCO Finland

Simple extraction of IUD

4.2

13.0

110

OAB91

SPAT

6.1

13.0

S20.2

ICD-10 Finland

Contusion of thorax

2.6

13.0

352

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.5

13.0

166

GD1AA

SPAT

2.4

13.0

110

436

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

3.0

13.0

237

SPAT1104

SPAT

Monitoring of emergency patient

2.2

13.0

140

620

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

12.9

189

950

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.2

12.9

133

580

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

24.1

12.9

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.9

12.8

125

D10

ICPC

Vomiting

2.2

12.8

132

573

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

17.0

12.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

12.8

207

1074

R07

ICPC

Sneezing/nasal congestion

2.1

12.7

143

644

M20.1

ICD-10 Finland

Hallux valgus (acquired)

3.0

12.7

229

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.2

12.7

199

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

12.7

126

538

S01GX02

ATC

levocabastine; ophthalmic

2.3

12.7

113

459

NA3BG

SPAT

5.9

12.7

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.5

12.7

155

R25.2

ICD-10 Finland

Cramp and spasm

4.3

12.7

100

1220

FHL

Arthroscopy

3.2

12.6

195

NG1AA

SPAT

4.0

12.6

118

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.9

12.6

192

975

NBG10

NOMESCO Finland

Acromioplastia

5.6

12.6

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.6

12.6

M65.3

ICD-10 Finland

Trigger finger

3.8

12.6

132

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

7.6

12.6

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.3

12.5

117

485

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

12.5

315

1868

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.9

12.5

180

897

N07BB01

ATC

disulfiram; oral

2.5

12.5

359

G54.0

ICD-10 Finland

Brachial plexus disorders

5.8

12.5

D82

ICPC

Teeth/gum disease

1.4

12.5

729

5197

WX111

NOMESCO Finland

Local infiltration anesthesia

6.8

12.5

SPAT1211

SPAT

Application of soft bandage

1.9

12.5

175

863

N05AA02

ATC

levomepromazine; systemic

2.2

12.4

130

570

G03DB08

ATC

dienogest; oral

46.8

12.4

R30.0

ICD-10 Finland

Dysuria

2.8

12.4

261

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.8

12.4

129

R03DA04

ATC

theophylline; systemic, rectal

2.1

12.4

145

664

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

21.1

12.4

M19.8

ICD-10 Finland

Other specified arthrosis

4.8

12.4

D02AE01

ATC

carbamide; topical

2.2

12.4

132

584

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

4.4

12.3

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.1

12.3

204

H93.1

ICD-10 Finland

Tinnitus

2.4

12.3

105

418

NG2AA

NOMESCO Finland

Patella X-ray examination

5.5

12.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

12.3

197

1021

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

12.2

164

797

SPAT1312

SPAT

General health counselling

1.4

12.2

778

5627

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

6.9

12.2

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.2

12.2

122

523

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

12.2

122

523

P76

ICPC

Depressive disorder

2.1

12.1

141

645

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.1

12.1

134

600

R5599

NOMESCO Finland

Other rehabilitation service

3.5

12.1

151

SPAT1058

SPAT

PEF monitoring instruction

2.1

12.1

143

659

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.3

12.1

176

K04.08

ICD-10 Finland

Other specified pulpit

2.2

12.1

117

495

N80.0

ICD-10 Finland

Endometriosis of uterus

8.4

12.1

DFF00

NOMESCO Finland

Pure tone audiometry

2.0

12.0

160

777

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

12.0

159

767

R03BB04

ATC

tiotropium bromide; inhalant

1.8

12.0

211

1129

SFA00

NOMESCO Finland

Small filling

1.7

12.0

235

1298

K59.1

ICD-10 Finland

Functional diarrhoea

2.5

12.0

359

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

7.0

12.0

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

5.9

11.9

D02

ICPC

Abdominal pain epigastric

2.4

11.9

388

G01AA10

ATC

clindamycin; vaginal

2.1

11.9

139

638

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

3.3

11.8

169

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

11.8

569

3910

D09

ICPC

Nausea

2.4

11.8

382

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

11.7

393

D07BC01

ATC

betamethasone and antiseptics; topical

1.8

11.7

216

1173

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

5.3

11.7

H60

ICD-10 Finland

Otitis externa

2.6

11.7

317

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

11.7

224

1232

G02BA03

ATC

plastic IUD with progestogen

2.5

11.6

335

C08CA05

ATC

nifedipine; systemic

2.0

11.6

159

778

M62.6

ICD-10 Finland

Muscle strain

3.8

11.6

118

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

7.9

11.6

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

7.9

11.6

SBB10

NOMESCO Finland

Teeth copy

2.1

11.6

128

575

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

16.9

11.6

K59.0

ICD-10 Finland

Constipation

2.2

11.5

113

480

R00.2

ICD-10 Finland

Palpitations

2.2

11.5

115

492

M43.0

ICD-10 Finland

Spondylolysis

6.9

11.5

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

11.5

163

D06BX01

ATC

metronidazole; topical

2.0

11.5

151

727

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

11.5

103

422

M50.3

ICD-10 Finland

Other cervical disc degeneration

7.2

11.4

V03AX01

ATC

[D]nalfurafine; oral

4.7

11.4

WZA90

NOMESCO Finland

Other doctors statement

1.5

11.4

444

2921

U71

ICPC

Cystitis/urinary infection other

2.3

11.4

109

458

M23

ICD-10 Finland

Internal derangement of knee

5.7

11.3

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.0

11.3

144

685

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

5.4

11.3

A04AA01

ATC

ondansetron; systemic, rectal

2.3

11.3

107

450

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

11.3

276

R01AC01

ATC

cromoglicic acid; nasal

2.5

11.3

316

M67.4

ICD-10 Finland

Ganglion

2.4

11.2

359

XCD10

NOMESCO Finland

Electrophysiological examination of eye

3.0

11.2

200

J01CF02

ATC

cloxacillin; systemic

3.5

11.2

141

N80.1

ICD-10 Finland

Endometriosis of ovary

3.8

11.2

113

K03.00

ICD-10 Finland

Approximal wear

2.4

11.2

371

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

11.2

1094

8440

N02CD02

ATC

galcanezumab; parenteral

+∞

11.2

79199

ICD-8 Finland

Headache

4.8

11.1

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1649

3931

3.25

307.65

1.3

1.2

iu/ml

24.5

38.8

1.50

461

1238

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1569

3564

3.40

307.65

1.3

1.2

u/ml

7.9

13.1

2.05

574

1276

(3013707) Erythrocyte sedimentation rate by Westergren method

6091

26651

2.78

307.65

4.3

3.3

mm/h

11.3

13.1

18.25

5638

24399

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7722

41109

3.26

284.55

15.5

12.9

mg/l

21.4

25.7

23.20

6248

30766

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7378

38652

2.82

269.75

5.6

4.3

mu/l

2.5

2.3

0.14

6833

35378

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6461

31833

2.41

267.47

4.6

3.7

pmol/l

14.6

14.7

5.24

5930

28883

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6023

29252

2.24

247.06

7.4

7.5

u/l

75.5

79.6

10.50

5644

27399

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7275

38680

2.58

235.51

13.8

12.4

ml/min/173m2

83.4

81.0

16.04

6055

30305

(3023103) Potassium [Moles/volume] in Serum or Plasma

7762

43146

2.88

215.93

17.0

15.6

mmol/l

3.9

8.31

7576

41607

(3019550) Sodium [Moles/volume] in Serum or Plasma

7742

43014

2.84

214.52

16.8

15.4

mmol/l

139.5

0.25

7575

41557

(3037467) Urinalysis macro (dipstick) panel - Urine

5691

27925

2.07

208.88

4.8

4.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6943

36966

2.29

203.35

5.6

5.2

mmol/mol

38.9

39.6

8.48

6471

34046

(40768797) Stomach Pathology biopsy report

1388

3922

2.65

195.82

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5497

27020

2.00

193.47

5.1

4.1

e6/l

3052.5

2265.0

0.22

378

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2044

7001

2.26

190.30

1.8

2.0

mg/l

1.0

1.6

13.14

1554

5401

(3013115) Eosinophils [#/volume] in Blood

4281

19714

1.91

175.41

6.4

6.6

e9/l

0.2

1.58

3748

17330

(3013650) Neutrophils [#/volume] in Blood by Automated count

4674

22199

1.90

173.75

8.9

10.2

e9/l

4.0

4.2

3.62

4040

19377

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7975

46190

2.84

171.41

10.8

8.7

u/l

25.4

24.7

0.71

7718

44252

(3037522) Nuclear Ab [Titer] in Serum

1346

3998

2.50

169.97

1.4

1.3

titre

513.0

562.5

0.40

273

812

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3633

16029

1.90

166.81

2.3

nmol/l

78.4

76.2

4.19

3231

14530

(3018010) Neutrophils/100 leukocytes in Blood

4049

18518

1.88

166.43

6.3

6.2

56.8

58.2

10.18

3788

17357

(3006315) Basophils [#/volume] in Blood

4139

19080

1.88

165.81

6.3

6.2

e9/l

0.0

1.12

3560

16556

(3019198) Lymphocytes [#/volume] in Blood

4240

19704

1.87

165.57

6.3

6.2

e9/l

2.0

1.9

2.21

3730

17336

(3002030) Lymphocytes/100 leukocytes in Blood

4096

18848

1.87

164.60

6.5

6.4

28.6

27.2

12.85

3824

17616

(3001604) Monocytes [#/volume] in Blood

4122

19007

1.87

164.57

6.2

e9/l

0.6

5.98

3543

16457

(40768804) Tissue Pathology biopsy report

3461

15106

1.90

163.21

2.1

2.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5320

26705

1.87

161.55

3.2

2.7

u/l

43.0

43.8

0.27

4974

24906

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4146

19255

1.86

160.49

5.5

6.4

umol/l

10.5

11.9

13.46

3906

18243

(3019069) Monocytes/100 leukocytes in Blood

3972

18235

1.86

158.95

6.8

6.6

8.3

8.6

4.78

3720

17088

(3006504) Eosinophils/100 leukocytes in Blood

3952

18151

1.85

157.46

6.4

6.3

2.8

2.7

1.63

3675

16951

(3044889) 12 lead EKG panel

5278

26634

1.85

154.27

3.7

3.6

—

(40761511) CBC panel - Blood by Automated count

7875

45822

2.58

154.07

13.5

12.1

—

(3022096) Basophils/100 leukocytes in Blood

3846

17621

1.84

153.05

6.4

0.7

2.45

3583

16459

(3026493) Urate [Moles/volume] in Serum or Plasma

2087

7780

2.06

152.57

2.4

3.0

umol/l

3236.3

6026.1

2.47

1784

6851

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4039

18826

1.83

151.63

3.1

3.0

ug/l

96.2

119.1

4.74

3795

17565

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1822

6476

2.13

150.57

1.7

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2905

12244

1.90

149.01

3.2

3.6

mmol/l

2.4

2.3

0.31

2488

10729

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4068

19091

1.82

148.24

5.8

8.1

mmol/l

1.2

9.32

3451

16044

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3695

16886

1.82

146.21

5.3

7.2

mmol/l

1.2

9.48

3357

15335

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3466

15581

1.83

144.05

2.1

1.9

pmol/l

98.2

94.1

4.61

1766

8247

(3018095) Leukocytes [#/volume] in Urine

3113

13559

1.85

142.83

3.9

e6/l

78.9

132.7

2.91

2111

9371

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2098

8030

2.00

141.18

1.3

1.2

u/ml

1.3

1.9

1.08

531

2140

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7452

42885

2.15

136.00

4.8

4.2

mmol/l

2.8

2.20

6899

39522

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7177

40753

2.04

135.19

4.7

3.9

mmol/l

5.8

5.9

2.74

6595

37179

(3007164) IgA [Mass/volume] in Serum or Plasma

1859

6916

2.03

134.41

1.5

g/l

2.3

2.4

0.82

1095

4216

(3033658) Prothrombin time (PT) actual/Normal

2329

9419

1.91

132.31

3.9

4.3

93.6

87.2

26.18

2271

9180

(42870588) Differential panel, method unspecified - Blood

2917

12774

1.81

128.30

6.1

6.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7302

42030

2.03

125.80

4.4

3.8

mmol/l

4.7

2.03

6804

38977

(36304419) Bacteria [Presence] in Urine

2418

10075

1.85

123.95

3.2

3.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7016

39975

1.92

121.41

3.9

3.5

mmol/l

1.3

1.2

25.93

6453

36764

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7239

41689

1.99

121.30

4.4

3.8

mmol/l

1.5

4.05

6707

38562

(3030467) Casts [#/volume] in Urine by Automated count

2463

10386

1.83

121.03

3.3

3.4

e6/l

0.4

0.5

1.53

1769

7805

(3002582) Erythrocytes [#/volume] in Urine

2653

11481

1.80

119.52

3.3

3.5

e6/l

67.4

98.6

0.66

1969

8763

(3013826) Glucose [Moles/volume] in Serum or Plasma

4575

23154

1.70

117.70

4.4

5.1

mmol/l

6.5

6.8

20.40

4311

20972

(3007461) Platelets [#/volume] in Blood

8255

50296

2.86

117.38

22.5

18.4

e9/l

259.7

250.9

27.81

8083

48533

(3035941) MCH [Entitic mass]

8259

50375

2.86

116.00

22.3

18.3

30.2

30.1

3.66

8168

49404

(3010813) Leukocytes [#/volume] in Blood

8261

50397

2.86

115.89

22.5

18.4

e9/l

6.8

6.7

1.85

8060

48448

(3026361) Erythrocytes [#/volume] in Blood

8260

50391

2.86

115.78

22.4

18.4

e12/l

4.5

0.48

8068

48473

(3024731) MCV [Entitic volume]

8259

50387

2.85

115.61

22.4

18.3

90.8

90.5

8.08

8167

49413

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2459

10486

1.81

115.53

2.1

2.2

u/l

216.0

236.1

0.13

2309

9822

(3000963) Hemoglobin [Mass/volume] in Blood

8262

50420

2.86

115.44

22.6

18.5

g/l

133.5

0.02

8170

49458

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5298

28002

1.70

114.67

3.5

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

1240

4257

2.12

108.63

2.1

2.9

ug/g

118.3

146.6

1.91

960

3361

(3044640) Blood type and Crossmatch panel - Blood

2698

12039

1.74

107.03

2.3

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

7082

40977

1.86

106.99

17.0

14.0

39.7

38.7

20.42

5464

29151

(3024561) Albumin [Mass/volume] in Serum or Plasma

3490

16722

1.68

106.62

4.2

5.6

g/l

36.0

34.9

23.94

3214

15524

(3009261) Glucose [Presence] in Urine by Test strip

4000

19866

1.66

106.47

3.8

3.5

estimate

0.0

0.69

725

3633

(3000492) Spirometry study

923

2836

2.34

105.29

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

3947

19590

1.65

104.73

3.7

3.4

estimate

0.0

1.34

721

3624

(3021601) Nitrite [Presence] in Urine by Test strip

3954

19688

1.65

103.03

5.2

4.8

estimate

0.0

0.36

739

3694

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2524

11224

1.73

99.97

2.5

2.6

u/l

58.1

59.6

0.37

2329

10378

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

957

3062

2.24

99.15

1.5

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1003

3308

2.18

96.44

2.5

2.6

u/l

68.2

41.1

0.36

849

2870

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2859

13256

1.67

96.36

3.6

3.5

ng/l

214.8

65.2

0.38

1710

9303

(40758558) Short blood count panel - Blood

2211

9586

1.74

94.91

7.0

7.5

—

(3018418) pH of Serum or Plasma

2527

11429

1.69

92.74

3.5

5.1

7.4

0.58

430

2210

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1595

6415

1.83

87.12

3.0

3.2

mmol/l

2.4

2.5

1.63

1359

5587

(3001019) Free T4 and TSH panel - Serum or Plasma

601

1656

2.55

85.89

1.7

1.5

—

(3008898) HLA-B27 [Presence]

343

685

3.47

85.28

1.1

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

1845

7841

1.74

83.32

2.6

2.9

e6/l

6.1

6.3

0.15

1590

6829

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2022

8841

1.70

82.36

2.2

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3697

18780

1.57

82.31

3.9

4.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2791

13358

1.60

79.35

3.1

3.2

u/l

32.1

34.5

0.88

2625

12686

(1002224) Polysomnography panel

407

949

2.98

79.15

1.1

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1527

6238

1.79

78.37

2.9

e6/l

1.0

1.2

0.90

751

3585

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1122

4173

1.93

77.13

2.4

2.9

umol/l

6.2

9.2

8.96

938

3599

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1474

5996

1.79

76.55

3.0

e6/l

3.4

3.1

0.37

700

3375

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

610

1814

2.36

73.95

1.3

au/ml

52.4

57.3

0.16

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

652

2023

2.27

71.72

2.4

2.3

au/ml

21.6

22.7

0.10

119

(4010399)

647

2005

2.27

71.37

1.4

1.5

—

(3022145) Colonoscopy Study observation

1006

3700

1.94

71.09

1.3

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1941

8708

1.65

70.05

1.6

1.5

nmol/l

20.8

19.9

1.71

1675

7626

(3002256) Pathology report gross observation

1161

4557

1.83

67.02

1.3

—

(3026782) Osmolality of Urine

1762

7867

1.64

64.02

2.8

3.1

mosm/kgh2o

520.0

534.6

1.90

1478

6661

(3007853) Bacteria identified in Skin by Aerobe culture

1051

4059

1.85

63.65

1.8

—

(3002385) Erythrocyte distribution width [Ratio]

6404

37737

1.54

63.21

18.7

16.1

13.7

0.59

6306

36754

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1629

7149

1.66

63.19

3.8

3.7

ng/l

359.0

551.3

0.62

1198

5637

(3000494) Fungus identified in Specimen by Culture

1010

3864

1.86

62.96

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

177

269

4.51

62.93

1.6

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

883

3244

1.93

62.17

2.3

2.2

nmol/l

365.2

402.3

5.85

813

2982

(36660697) Celiac disease serology panel - Serum

791

2801

1.99

61.86

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

2612

12913

1.52

60.64

3.3

2.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

599

1928

2.18

60.09

1.3

iu/l

25.1

27.0

0.68

527

1656

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1727

7787

1.62

59.80

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

209

378

3.79

59.73

1.6

1.5

e6/l

9485.1

16367.2

1.45

137

275

(3021589) Normoblasts [#/volume] in Blood

3502

18460

1.47

58.83

9.9

9.7

e9/l

0.0

0.09

2799

15221

(3013139) Helicobacter pylori Ag [Presence] in Stool

644

2159

2.09

58.24

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

614

2032

2.12

57.39

1.3

u/ml

165.9

297.0

2.52

566

1883

(3013512) EKG study

2150

10327

1.54

56.21

4.1

3.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1591

7198

1.60

53.63

1.8

1.7

nmol/l

1083.0

1174.0

3.34

1190

5451

(3015171) Extractable nuclear Ab [Units/volume] in Serum

393

1119

2.43

52.09

1.3

1.2

u/ml

0.3

1.1

1.43

(3032080) INR in Blood by Coagulation assay

2991

15594

1.45

51.14

8.1

12.2

inr

1.2

1.4

22.16

838

4638

(3011397) Hemoglobin [Presence] in Urine by Test strip

1881

8956

1.53

50.32

3.5

3.4

—

(3019225) pH of Specimen

825

3180

1.83

49.64

3.7

5.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

386

1115

2.40

49.59

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2084

10186

1.50

49.08

2.9

3.3

ng/l

1263.2

2031.0

9.02

1753

8964

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

306

797

2.65

48.57

1.4

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

293

746

2.71

48.57

1.3

u/ml

58.8

51.8

0.12

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2923

15323

1.43

47.65

3.9

3.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2063

10114

1.49

47.64

1.6

mmol/l

1.4

1.3

3.42

1753

8627

(3042936) Bacteria identified in Isolate by Culture

1147

4943

1.65

46.39

2.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2090

10329

1.48

46.14

2.3

mg/l

2.9

3.0

0.89

1782

8856

(3003338) MCHC [Mass/volume]

6439

38859

1.44

45.69

19.5

16.2

g/l

331.6

331.9

1.38

6396

38426

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

517

1755

2.05

45.00

1.1

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2178

10935

1.46

44.00

3.5

3.3

—

(3025941) Bacteria identified in Stool by Culture

548

1920

1.99

43.73

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

276

726

2.61

42.98

1.2

—

(3017732) Neutrophils [#/volume] in Blood

621

2296

1.89

42.34

2.9

3.4

e9/l

4.0

4.1

0.27

506

1808

(3044941) Cell count panel - Synovial fluid

145

262

3.78

41.57

1.5

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

962

4092

1.66

40.59

4.6

4.1

31.8

33.3

3.49

678

2770

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

726

2865

1.77

40.12

1.2

iu/ml

118.2

158.2

2.05

250

1093

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

256

673

2.61

39.92

1.4

1.3

u/ml

16.9

15.3

0.04

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

258

683

2.59

39.69

1.4

1.3

u/ml

3.7

9.1

1.32

112

(3023368) Bacteria identified in Blood by Culture

2031

10230

1.44

39.63

4.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

205

480

2.92

39.56

1.5

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

995

4299

1.63

39.43

1.6

1.4

2.12

878

3794

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

652

2508

1.81

39.18

3.1

3.6

pmol/l

4.4

0.32

592

2234

(3003327) Ova and parasites identified in Stool by Light microscopy

371

1189

2.15

37.40

1.8

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

292

848

2.37

37.06

1.8

2.2

—

(40768443) Skin Pathology biopsy report

419

1416

2.05

36.84

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

221

566

2.68

36.27

1.2

1.3

u/ml

9.4

12.6

0.14

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

225

582

2.65

36.23

1.3

u/ml

34.1

34.2

0.00

(40760892) CBC W Ordered Manual Differential panel - Blood

1722

8563

1.44

35.41

3.9

4.9

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

207

3.85

34.57

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

207

3.85

34.57

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

208

3.83

34.35

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

293

887

2.27

33.88

1.4

ug/g

273.4

256.8

0.65

167

530

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

567

2188

1.80

33.62

2.5

3.4

u/ml

40.4

83.5

2.93

547

2124

(40759836) Histone Ab [Presence] in Serum by Immunoblot

114

205

3.79

32.97

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

114

207

3.75

32.55

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

114

207

3.75

32.55

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

308

969

2.18

32.50

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

305

962

2.18

31.99

1.1

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

177

433

2.79

31.67

1.2

1.1

au/ml

9.8

14.1

0.41

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

300

955

2.16

30.77

1.1

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

649

2683

1.68

30.17

2.6

2.8

g/l

10.2

10.8

2.75

597

2466

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1270

6131

1.46

29.97

1.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

317

1050

2.07

29.39

1.7

1.9

g/l

1.2

1.1

3.81

302

998

(3022948) Iron [Moles/volume] in Serum or Plasma

1353

6645

1.44

29.10

2.2

3.1

umol/l

13.3

12.7

1.92

1262

6179

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1276

6203

1.45

28.97

2.1

3.1

g/l

2.4

2.3

8.44

1179

5784

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1648

8402

1.40

28.71

1.7

1.6

pmol/l

39778230.3

31425337.4

0.19

1350

7004

(3009508) Creatinine [Moles/volume] in Urine

2229

11949

1.35

28.34

3.0

3.5

mmol/l

7.2

7.1

0.05

1857

10147

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

389

1406

1.91

28.27

2.0

u/l

39.3

38.2

0.46

348

1228

(3020961) Endomysium IgA Ab [Titer] in Serum

431

1618

1.84

27.88

1.1

titre

243.0

248.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

106

206

3.50

27.58

1.5

58.1

60.1

0.15

144

(3024891) Influenza virus A+B Ag [Presence] in Specimen

265

840

2.16

27.49

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

135

308

2.99

27.35

1.6

iu/ml

24.7

30.5

—

(4094501)

225

669

2.30

27.16

1.1

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1304

6436

1.43

27.14

2.8

3.8

mmol/l

0.8

0.04

1185

6000

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

307

1036

2.03

27.10

1.7

1.9

g/l

0.2

0.28

293

981

(44816559) Phosphatidylethanol [Mass/volume] in Blood

210

611

2.35

26.62

1.2

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

10.02

26.44

1.7

1.8

ug/l

3.1

2.3

0.36

(3047007) Chlamydophila sp Ab [Presence] in Serum

153

386

2.70

25.94

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

324

1144

1.94

25.23

3.1

3.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

661

2875

1.60

25.06

1.7

1.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1175

5772

1.43

24.93

2.2

3.3

22.8

22.2

0.72

1046

4867

(1761868) Lipid panel - Serum or Plasma

2657

14817

1.30

24.91

2.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

151

387

2.66

24.87

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

150

391

2.61

23.92

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

468

1894

1.70

23.46

1.3

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

505

2100

1.66

22.87

1.8

1.9

g/l

1.2

1.4

1.07

464

1920

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

283

989

1.96

22.72

2.0

2.1

g/l

37.7

37.2

0.77

246

840

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

137

3.81

22.71

1.1

iu/ml

14.3

7.8

0.55

(3004588) Protein electrophoresis panel - Serum or Plasma

541

2301

1.62

22.43

2.2

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

4.60

21.92

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1092

5415

1.41

21.79

2.1

1.9

—

(3012516) Albumin [Mass/volume] in Urine

2032

11091

1.31

21.77

3.0

3.6

mg/l

452.5

433.9

0.05

1174

7142

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

143

384

2.54

21.55

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1269

6471

1.38

21.45

2.1

2.4

29.6

30.0

1.61

1240

6283

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

296

1078

1.88

21.07

2.2

2.4

g/l

0.5

0.8

1.63

258

917

(3039162) Centromere protein B Ab [Units/volume] in Serum

143

390

2.50

20.89

1.2

1.3

u/ml

39.1

53.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

176

529

2.27

20.82

1.6

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

1934

10548

1.30

20.67

4.1

3.7

estimate

0.0

0.23

737

3495

(3004616) Nuclear Ab [Presence] in Serum

114

278

2.79

20.66

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

269

957

1.92

20.54

2.1

2.2

g/l

0.0

0.30

249

863

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

502

2143

1.61

20.50

1.9

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2134

11803

1.29

20.48

3.7

4.4

mg/mmol

7.3

11.6

5.18

1232

7766

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

253

883

1.96

20.42

2.1

2.2

g/l

0.0

0.73

233

794

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

249

868

1.96

20.17

2.1

2.2

g/l

0.0

0.00

232

790

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

430

1776

1.67

19.99

2.4

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

215

714

2.06

19.90

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

965

4768

1.41

19.54

2.0

1.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

153

3.41

19.51

1.4

1.3

28.9

32.9

0.32

104

(3025018) Bordetella pertussis Ab [Titer] in Serum

118

3.79

19.39

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

159

472

2.29

19.38

1.1

u/ml

1.4

3.4

2.09

222

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

316

1212

1.79

19.11

2.0

2.3

g/l

3.1

0.01

261

922

(3024980) IgG subclass 4 [Mass/volume] in Serum

169

523

2.20

18.71

1.5

g/l

0.7

0.8

0.49

139

397

(3045414) Leukocytes [Presence] in Urine

387

1583

1.68

18.67

1.9

1.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

378

1539

1.69

18.55

1.6

1.7

u/ml

5.9

13.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

274

1016

1.84

18.49

1.1

u/ml

1.2

9.1

4.84

128

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

670

3133

1.48

18.16

2.9

5.6

ng/l

81.6

111.5

15.45

573

2746

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

308

1191

1.77

18.14

1.6

1.7

titre

400.0

342.8

0.12

(3034770) Mitochondria Ab [Titer] in Serum

266

985

1.85

18.03

1.2

1.3

titre

1290.0

1012.9

—

(3035320) C reactive protein [Mass/volume] in Body fluid

100

245

2.77

18.03

3.8

2.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

315

1231

1.75

17.90

1.9

2.2

g/l

9.6

10.9

5.51

274

1012

(3038177) Helicobacter pylori Ab [Presence] in Serum

172

547

2.14

17.83

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

1315

1.72

17.76

2.0

2.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

771

3722

1.44

17.70

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

133

380

2.38

17.69

1.3

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

1319

1.72

17.58

2.0

2.2

g/l

7.4

7.3

0.53

262

939

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

130

369

2.40

17.54

1.3

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

330

1315

1.72

17.52

2.0

2.2

g/l

3.8

0.15

256

904

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

471

2058

1.57

17.46

7.7

10.2

mmol/l

24.4

24.2

0.60

441

1917

(3010144) Erythrocytes [#/volume] in Synovial fluid

153

3.24

17.12

1.4

1.3

e6/l

232094.5

129771.4

0.39

(3042517) Benzodiazepines panel - Urine

8.79

17.11

2.3

1.8

—

(4035726)

710

3397

1.45

17.09

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

120

3.56

17.02

1.5

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

264

997

1.81

16.84

1.3

titre

85.3

103.2

0.34

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

264

997

1.81

16.84

1.4

1.6

iu/ml

37.0

9.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

872

4340

1.39

16.83

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

105

3.74

16.81

1.8

1.9

umol/l

156.7

153.3

0.02

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

876

4376

1.39

16.53

1.8

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

367

2.35

16.51

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

175

3.02

16.42

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

369

2.34

16.32

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

127

369

2.34

16.32

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

127

371

2.33

16.13

1.3

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

298

1183

1.72

16.06

3.9

4.3

mmol/l

24.9

24.7

0.66

271

1065

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

819

4072

1.39

15.87

6.6

7.1

—

(40768793) Breast Pathology biopsy report

238

889

1.83

15.75

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

184

633

1.98

15.56

1.1

u/ml

3.2

5.4

1.87

101

345

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

199

707

1.92

15.36

1.1

u/ml

0.8

2.0

1.51

306

(3022217) INR in Platelet poor plasma by Coagulation assay

993

5135

1.34

15.01

20.7

31.5

inr

1.3

1.6

6.40

140

542

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

146

3.11

14.83

1.2

1.5

u/l

5.1

5.7

0.47

120

(3008401) Mugwort IgE Ab [Units/volume] in Serum

175

602

1.98

14.83

1.1

u/ml

0.7

1.3

0.97

282

(3020630) Protein [Mass/volume] in Serum or Plasma

624

2997

1.43

14.69

2.3

2.5

g/l

66.5

65.9

1.15

564

2718

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

125

379

2.24

14.62

1.1

u/ml

0.1

0.3

1.14

(3028707) Methadone [Presence] in Urine by Screen method

178

622

1.95

14.44

2.7

2.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

219

820

1.82

14.42

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

219

820

1.82

14.42

1.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

773

3872

1.38

14.29

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

232

887

1.78

14.27

2.1

2.2

mg/l

10.4

12.1

1.73

221

840

(4024509)

101

283

2.42

14.10

1.6

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.96

14.09

1.3

2.2

3.1

0.33

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

225

856

1.79

14.07

1.4

1.3

mg/l

481.7

547.9

1.53

215

814

(3022313) Gas panel - Capillary blood

338

1441

1.60

13.93

3.7

4.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

319

1343

1.62

13.84

2.0

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

476

2197

1.49

13.75

3.5

3.9

kpa

5.2

5.1

0.86

433

2041

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

356

1545

1.58

13.63

1.5

1.7

mg/l

3.4

3.3

0.03

256

955

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

721

3604

1.38

13.49

2.1

2.3

g/l

0.2

8.22

638

3351

(3014111) Lactate [Moles/volume] in Serum or Plasma

698

3471

1.39

13.47

7.1

7.9

mmol/l

1.3

1.4

1.88

664

3341

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

247

979

1.72

13.45

1.4

pmol/l

157.9

121.1

0.35

239

950

(40761536) Microorganisms panel - Urine sediment

688

3421

1.39

13.28

4.0

3.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

190

700

1.85

13.20

1.6

1.5

nmol/l

42.5

49.0

2.30

180

687

(3009343) pH of Capillary blood

468

2172

1.48

13.17

3.4

3.9

7.4

0.20

331

(3045683) HLA typing for celiac disease panel - Blood or Tissue

188

2.70

13.09

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

191

713

1.82

12.75

1.5

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

138

461

2.03

12.73

1.4

1.3

nmol/l

0.2

0.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

240

964

1.70

12.49

1.6

iu/ml

0.3

3.1

0.57

247

(3010726) Horse dander IgE Ab [Units/volume] in Serum

168

606

1.89

12.48

1.1

u/ml

2.7

1.8

0.17

147

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

351

1551

1.55

12.45

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

225

889

1.73

12.42

1.2

—

(3022621) pH of Urine by Test strip

563

2737

1.41

12.39

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

455

4326

0.69

12.36

1.4

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

199

760

1.78

12.34

1.3

mmol/l

3.7

3.8

1.22

188

714

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

136

458

2.02

12.30

1.4

1.3

nmol/l

0.6

2.1

0.79

129

436

(3021879) Hepatitis B virus core Ab [Presence] in Serum

666

3337

1.37

12.27

1.4

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

536

2588

1.42

12.26

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

319

1385

1.57

12.22

2.1

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

399

1833

1.49

11.83

1.7

mu/l

321.9

364.5

0.64

357

1618

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

892

4697

1.31

11.80

3.7

4.7

u/l

239.7

249.9

1.19

842

4488

(4062490)

104

323

2.19

11.59

1.5

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

132

1649

0.53

11.54

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

104

324

2.18

11.51

1.5

1.3

g/l

0.4

0.5

2.16

223

(3026389) Candida sp identified in Specimen by Organism specific culture

144

508

1.93

11.46

1.4

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

104

325

2.17

11.42

1.5

1.3

g/l

6.6

7.5

1.56

228

(3028192) IgG subclass 2 [Mass/volume] in Serum

104

325

2.17

11.42

1.5

1.3

g/l

3.1

3.2

0.33

226

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

294

1275

1.57

11.35

2.0

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

199

2.52

11.33

3.3

2.7

mu/l

22.1

21.5

0.05

186

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

166

617

1.83

11.28

1.4

1.3

u/l

24.7

25.9

0.16

132

506

(3017446) Testosterone [Moles/volume] in Serum or Plasma

423

1993

1.45

11.05

2.3

1.9

nmol/l

11.8

11.1

0.89

366

1753

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

166

1919

0.58

11.03

1.7

1.8

—

(3016879) Cocaine [Presence] in Urine

324

1446

1.53

11.03

2.1

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1207

0.47

11.02

1.2

—

(3011288) Drugs identified in Urine by Screen method

249

1045

1.62

11.01

3.3

2.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

444

2114

1.44

10.98

3.4

3.9

mmol/l

1.7

1.8

0.29

335

1537

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

979

5273

1.28

10.89

1.8

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

144

2.77

10.88

1.5

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

123

419

1.99

10.83

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

624

3157

1.36

10.82

3.9

4.7

0.1

0.68

172

892

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

105

338

2.11

10.74

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

598

3011

1.36

10.69

3.8

4.6

0.7

0.05

130

695

(3019150) Specific gravity of Urine by Refractometry

1544

8785

1.22

10.61

4.0

3.6

kg/l

1.0

0.58

258

1633

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

122

419

1.98

10.52

1.8

1.6

pmol/l

184.3

170.4

0.52

112

397

(3000991) Gas panel - Venous blood

675

3474

1.34

10.46

7.9

9.8

—

(3028300) Cannabinoids [Presence] in Urine

348

1596

1.49

10.44

2.1

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

748

3910

1.32

10.40

3.5

3.6

—

(3027008) Opiates [Presence] in Urine

347

1593

1.49

10.36

2.1

1.6

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

160

2.62

10.33

1.3

1.2

u/ml

2.2

14.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

982

5332

1.27

10.22

1.5

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

132

472

1.90

10.15

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

216

2290

0.63

10.11

1.4

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

128

454

1.91

10.09

1.1

u/ml

4.9

3.9

0.20

206

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

191

766

1.70

10.08

1.5

e6/l

727.4

1436.3

0.95

160

629

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

191

767

1.69

10.03

1.5

e6/l

21.1

55.1

1.33

151

597

(3017181) Myelocytes/100 leukocytes in Blood

650

3350

1.33

9.98

3.9

4.6

0.8

0.9

0.35

187

960

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

171

2.53

9.98

1.3

1.2

u/ml

28.9

21.6

—

(3000764) Benzodiazepines [Presence] in Urine

343

1584

1.48

9.96

2.1

1.6

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

134

485

1.88

9.95

1.1

u/ml

2.0

4.4

1.57

201

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

239

1020

1.60

9.92

1.7

1.9

iu/l

4.1

0.00

386

(1001926) Buprenorphine [Presence] in Urine by Screen method

270

1186

1.55

9.91

2.3

1.7

—

(3027944) Amphetamines [Presence] in Urine

339

1568

1.48

9.77

1.9

1.6

—

(3024263) Appearance of Synovial fluid

3.23

9.76

1.5

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

162

626

1.76

9.76

3.2

3.3

u/ml

64.1

37.0

0.55

155

606

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

343

2.04

9.70

2.1

1.9

mg/l

36.6

28.2

0.33

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

173

684

1.72

9.63

1.5

—

(3045424) Erythrocytes [Presence] in Urine

154

589

1.78

9.61

1.6

1.5

—

(3023410) Appearance of Cerebral spinal fluid

322

2.06

9.56

1.6

1.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

251

2.21

9.54

2.2

2.1

nmol/l

17.9

18.9

0.50

239

(3050129) First trimester maternal screen panel - Serum or Plasma

302

2949

0.68

9.50

1.4

—

(3025159) Blasts/100 leukocytes in Blood

584

2988

1.34

9.42

3.9

4.7

0.5

0.1

0.41

143

748

(3025130) Human papilloma virus identified in Specimen

174

695

1.70

9.35

1.6

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

574

2933

1.34

9.34

2.4

3.0

ml/min/173m2

72.9

63.0

6.83

245

1221

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1014

5603

1.25

9.06

4.1

8.6

mmol/l

1.0

1.1

3.54

919

5233

(40761535) Cells panel - Urine sediment

529

2685

1.35

9.01

3.2

3.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

682

3599

1.30

8.85

1.9

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

409

1999

1.40

8.79

4.8

6.2

mmol/l

24.4

24.0

1.78

378

1792

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

765

4109

1.28

8.67

3.4

4.2

ug/l

8.0

21.3

3.82

595

3351

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

253

2.14

8.65

1.4

1.3

u/ml

0.8

0.5

0.23

111

(3016018) Differential panel - Cerebral spinal fluid

340

1.97

8.62

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

574

2974

1.32

8.51

2.1

2.3

ug/l

7.3

9.2

1.22

473

2588

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

203

2.27

8.44

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

266

1212

1.49

8.31

2.5

2.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

180

2.33

8.20

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

203

2.23

8.05

1.5

umol/l

57.9

66.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.33

8.04

1.1

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

258

1178

1.49

8.00

1.3

u/l

9.7

9.8

0.02

211

966

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

120

452

1.80

7.95

1.1

g/l

1.4

1.6

2.44

112

413

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

201

2.22

7.85

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

181

768

1.60

7.79

1.5

nmol/l

0.3

0.5

2.00

150

634

(3014051) Protein [Presence] in Urine by Test strip

194

840

1.57

7.68

2.0

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

114

428

1.81

7.65

1.5

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

217

2.15

7.61

1.0

u/ml

0.2

1.2

1.21

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

623

0.40

7.59

9.9

13.1

nmol/l

835.8

2445.8

0.51

604

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

102

371

1.86

7.57

3.4

3.0

nmol/l

4.6

7.5

0.70

360

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

340

1.89

7.41

1.8

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

198

2.19

7.36

1.2

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

130

514

1.72

7.35

1.5

1.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

289

1378

1.43

7.21

2.1

2.6

ug/l

213.3

719.4

3.16

267

1301

(3032057) Clostridioides difficile [Presence] in Stool

3.22

7.20

1.8

2.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.01

7.15

1.5

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

335

1.88

7.13

3.5

4.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

233

1069

1.48

7.10

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

282

1.95

6.88

1.6

1.2

mmol/l

2.2

2.1

0.27

265

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.96

6.76

1.2

1.3

98.8

96.7

0.14

(3027801) Oxygen [Partial pressure] in Arterial blood

819

4568

1.23

6.70

6.3

7.8

kpa

12.6

12.7

0.12

770

4354

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

180

2.18

6.66

1.0

nmol/l

0.1

9.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

819

4572

1.23

6.64

6.3

7.8

kpa

5.1

5.0

0.94

771

4355

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

2.43

6.61

1.1

1.0

u/ml

6.8

8.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.92

6.61

1.2

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

816

4556

1.23

6.61

2.3

2.9

1.8

0.25

712

4049

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

109

2.54

6.58

1.1

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

278

1344

1.41

6.46

2.6

2.9

179.2

192.0

1.59

255

1283

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

135

2.35

6.44

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

616

3343

1.26

6.44

2.5

3.3

ng/l

176.8

271.0

6.73

543

3089

(3020491) Glucose [Moles/volume] in Blood

294

1.89

6.42

1.9

1.6

mmol/l

6.7

6.2

0.61

204

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

412

2123

1.32

6.42

2.4

2.1

u/l

5911.7

7634.6

0.48

151

959

(3012501) Base excess in Blood by calculation

201

915

1.49

6.41

2.5

4.6

mmol/l

2.8

0.10

136

615

(3003396) Base excess in Arterial blood by calculation

817

4578

1.22

6.39

6.3

7.8

mmol/l

0.9

1.1

0.37

634

3551

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

2.34

6.35

1.1

91.4

82.4

1.09

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

508

2698

1.29

6.34

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

203

2.07

6.25

1.0

u/ml

0.3

0.7

0.87

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.73

6.25

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

274

1330

1.40

6.24

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

133

2.34

6.23

1.1

1.2

92.7

81.5

0.84

(3019832) Treponema pallidum Ab [Presence] in Serum

857

6844

0.83

6.12

1.6

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

309

1538

1.37

6.07

1.3

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.59

6.01

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

355

1.77

6.01

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

198

2.05

5.95

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

317

1.82

5.93

1.2

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

177

2.10

5.83

1.8

1.7

—

(44813793)

223

1.97

5.82

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

246

1188

1.41

5.80

2.8

3.1

mg/l

32.5

55.8

2.50

202

939

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

320

1.80

5.77

1.2

titre

155.0

178.6

0.08

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

276

1361

1.38

5.76

1.4

—

(3036489) Thrombin time

337

1717

1.34

5.71

2.1

2.4

21.7

21.6

0.12

298

1524

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

258

1.89

5.70

1.1

1.0

mg/l

288.3

300.7

0.86

233

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

611

3366

1.24

5.63

3.3

4.5

mmol/l

1.2

0.76

537

2963

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

198

2.02

5.62

1.1

u/l

1.0

1.2

1.43

(3034860) Kappa light chains.free [Mass/volume] in Serum

245

1190

1.40

5.60

2.8

3.1

mg/l

266.5

61.0

0.44

201

939

(3014576) Chloride [Moles/volume] in Serum or Plasma

885

5065

1.20

5.58

7.1

7.8

mmol/l

104.3

0.13

875

4944

(3013005) Retinol [Moles/volume] in Serum or Plasma

149

2.18

5.57

1.3

1.8

umol/l

1.9

0.19

143

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

396

1.69

5.48

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

3.17

5.46

1.7

1.1

g/l

38.6

41.3

0.27

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

133

2.24

5.44

2.6

3.0

umol/l

26.6

28.2

0.52

(3042733) HLA Ab [Presence] in Serum

293

0.28

5.38

5.0

5.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

235

1.90

5.35

1.1

1.2

u/l

17.0

23.4

1.29

213

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

242

1.87

5.21

1.1

1.2

u/l

74.1

100.3

1.89

220

(3008295) Osmolality of Serum or Plasma

102

418

1.65

5.18

1.9

1.4

mosm/kgh2o

280.3

283.5

0.57

336

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.76

5.13

1.7

1.8

ug/l

0.5

0.11

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

338

1.72

5.10

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

2.06

5.09

2.0

—

(3024928) Oxygen saturation in Venous blood

187

884

1.44

5.02

5.4

4.5

—

(3036603) Volume of Urine

261

1.81

4.96

1.4

1.6

1797.0

1949.9

—

(3010421) pH of Blood

217

1058

1.39

4.91

2.5

4.5

7.4

0.85

200

890

(3011985) Renin [Units/volume] in Plasma

119

517

1.56

4.81

1.4

1.6

mu/l

44.1

49.4

0.23

108

459

(3013166) Neutrophils/100 leukocytes in Synovial fluid

3.08

4.80

1.4

1.2

63.4

60.9

0.11

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

236

1172

1.37

4.78

2.6

3.0

ratio

1.2

5.9

1.63

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

3.73

4.78

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

146

665

1.49

4.75

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

183

871

1.43

4.75

1.4

1.6

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.97

4.75

1.1

1.4

35.2

38.5

0.14

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.02

4.65

1.8

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

252

1.80

4.64

1.3

1.7

u/ml

22.4

23.0

0.03

(3006653) Thiamine [Moles/volume] in Blood

157

2.02

4.60

1.3

1.2

nmol/l

133.1

130.1

0.16

157

(3030981) Hyaline casts [#/volume] in Urine by Automated count

387

2074

1.27

4.58

2.6

3.0

e6/l

0.2

0.3

1.96

370

2036

(3017354) Segmented neutrophils/100 leukocytes in Blood

339

1.68

4.57

4.2

3.8

56.2

59.6

0.56

213

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

126

562

1.52

4.55

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

240

1206

1.35

4.54

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

2.48

4.53

1.4

3.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

284

1.74

4.53

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

291

1.72

4.43

1.8

1.7

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

332

1.67

4.42

1.1

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

123

551

1.51

4.37

1.4

1.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.89

4.36

1.7

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

129

2.10

4.31

1.3

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

366

1.63

4.30

1.4

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

108

472

1.55

4.30

1.2

1.4

pmol/l

361.2

375.4

0.06

378

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

424

1.58

4.29

1.1

1.2

u/l

47.5

63.6

2.33

295

(3006462) Nitrate [Presence] in Urine

157

1.98

4.27

2.9

2.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

109

478

1.54

4.27

1.6

1.9

90.6

89.9

0.65

109

467

(3008757) Leukocyte morphology finding [Identifier] in Blood

341

1.65

4.25

4.1

4.9

—

(4211845)

172

1.93

4.22

2.8

2.0

—

(3014271) Vancomycin [Susceptibility]

177

1.91

4.20

3.0

3.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

276

1.72

4.18

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

639

0.57

4.17

1.5

1.6

—

(3024471) HLA-A [Type]

241

0.31

4.13

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1330

9966

0.88

4.10

4.9

4.4

ug/l

2.8

3.5

0.51

1186

8867

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

294

1.68

4.05

1.1

mg/l

36.5

54.3

1.44

240

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

110

2.15

4.03

1.3

1.2

g/l

0.3

0.25

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

337

1.63

3.98

1.4

1.8

—

(3028433) Virus identified in Specimen by Culture

111

2.13

3.95

1.3

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

135

631

1.45

3.94

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

102

450

1.53

3.93

3.1

3.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

287

1.67

3.90

1.2

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.23

3.90

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

282

1.68

3.89

1.1

mg/l

237.1

296.4

1.05

241

(4268621)

102

451

1.53

3.89

2.5

2.4

—

(3024932) HLA-DR beta [Type]

233

0.32

3.89

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

103

2.16

3.88

1.2

110.1

116.2

0.65

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.50

3.88

2.1

1.7

umol/l

60.7

47.0

0.46

(3051651) Icteric interference index of Serum or Plasma

267

1.70

3.88

3.1

3.9

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

213

1081

1.34

3.84

1.8

1.6

—

(3002619) Bacteria identified in Specimen by Culture

2.55

3.83

1.5

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.66

3.82

1.4

1.6

mg/l

0.8

4.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

122

2.05

3.80

1.3

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

132

620

1.44

3.77

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

437

2434

1.22

3.73

1.6

1.5

—

(4146454)

328

1.61

3.70

2.4

2.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

141

677

1.41

3.59

1.3

u/ml

4.0

4.1

0.07

307

(3047352) Trisomy 18 risk [Likelihood] in Fetus

225

1957

0.77

3.59

1.4

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

103

2.10

3.52

1.0

1.1

u/ml

0.9

1.3

0.28

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

270

0.40

3.52

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

275

1.65

3.51

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

230

1989

0.77

3.51

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.43

3.50

1.2

1.1

umol/24h

0.7

0.6

0.50

(3005033) Fetal Nuchal fold Thickness US

225

1948

0.77

3.47

1.4

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

261

1.66

3.45

1.1

—

(40768446) Kidney Pathology biopsy report

314

0.45

3.42

1.6

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

262

1.65

3.40

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

286

2399

0.80

3.40

1.4

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.25

3.38

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

134

648

1.40

3.31

1.3

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

281

0.43

3.29

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

144

707

1.38

3.26

1.3

u/ml

2.2

4.9

1.40

256

(3006270) Folate [Moles/volume] in Blood

329

1.56

3.25

1.1

nmol/l

377.0

358.7

0.30

254

(3000060) B lymphocytes [#/volume] in Blood

2.12

3.20

1.9

2.3

e6/l

182.5

949.6

0.47

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

337

1.55

3.15

3.9

4.9

u/ml

64.5

122.2

0.65

113

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.52

3.13

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

129

627

1.39

3.12

3.6

3.4

1.9

1.7

0.25

101

493

(40760888) Immunoglobulin light chains.free panel - Serum

181

929

1.32

3.10

2.8

3.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

162

1.79

3.08

1.6

1.8

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.08

3.04

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

268

2232

0.80

3.02

3.4

4.1

mmol/l

25.6

25.0

2.17

260

2164

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

136

0.30

3.02

8.0

12.0

mmol/l

4.9

5.1

—

136

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.04

3.01

1.2

113.2

108.8

0.29

(4015189)

2.29

2.99

2.4

2.7

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

267

1448

1.25

2.99

2.3

2.6

94.9

90.9

2.12

246

1362

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

144

1.83

2.99

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

1.78

2.97

1.6

1.9

nmol/l

1.4

16.7

0.55

138

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.06

2.97

1.2

77.4

82.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

147

738

1.35

2.94

5.3

6.0

umol/l

354.6

382.4

1.33

117

660

(3003181) Sodium [Moles/volume] in Urine

148

744

1.35

2.93

1.4

1.3

mmol/l

63.7

62.3

0.13

120

587

(3024869) Neuronal Ab [Presence] in Serum

2.42

2.92

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

136

1.84

2.88

1.4

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

136

1.84

2.88

1.4

2.4

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

151

1.79

2.87

2.1

2.0

ug/l

67.9

75.8

0.23

145

(3004775) Volume in Urine collected for unspecified duration

449

0.58

2.84

1.7

2.6

723.1

664.8

0.41

334

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.34

2.83

1.2

1.3

nmol/l

564.1

515.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

141

708

1.35

2.83

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.01

2.82

1.2

1.1

60.8

74.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.01

2.82

1.3

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

576

3386

1.16

2.74

2.4

2.8

e9/l

70.6

68.2

0.72

411

2559

(4306422)

129

643

1.36

2.73

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

278

2278

0.82

2.72

1.4

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

124

615

1.36

2.71

1.1

126.2

111.0

5.26

110

565

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

278

2276

0.82

2.70

1.4

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

277

2267

0.82

2.68

1.4

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

171

891

1.30

2.68

2.1

2.8

umol/l

31.1

33.0

0.54

133

755

(3016031) Almond IgE Ab [Units/volume] in Serum

2.83

2.66

1.1

1.0

u/ml

0.0

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

168

874

1.30

2.66

2.1

2.8

16.2

16.0

0.30

489

(1616796) Gas panel - Central venous blood

186

981

1.28

2.66

2.2

4.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

140

1.79

2.66

1.4

2.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

140

1.79

2.66

2.2

2.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

463

1.42

2.65

1.1

1.2

94.3

89.2

1.14

436

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

269

1482

1.23

2.65

3.4

2.9

g/l

3.6

0.00

258

1406

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.70

2.65

1.0

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.29

2.62

1.0

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

408

1.44

2.62

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

277

2261

0.82

2.62

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

147

753

1.32

2.61

1.7

4.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.10

2.60

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

173

1.68

2.52

2.3

2.5

umol/l

58.2

51.9

0.43

145

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.97

2.52

1.3

nmol/l

97.0

121.0

0.57

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

2.50

0.0

9.3

—

432.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

435

1.41

2.49

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.21

2.49

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.09

2.48

1.0

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

190

1.64

2.46

1.7

1.3

53.6

64.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.47

2.42

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

438

1.41

2.41

1.7

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

250

1.54

2.39

2.4

2.8

e9/l

0.3

0.02

217

(3047189) Immunofixation for 24 hour Urine

141

1.72

2.34

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.07

2.33

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

181

970

1.26

2.32

1.2

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

2.32

0.0

3.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

2.32

0.0

3.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.11

2.31

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

162

859

1.28

2.27

2.0

2.3

umol/l

5.4

6.2

0.48

108

641

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

231

1276

1.23

2.27

2.5

2.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

352

2024

1.18

2.26

1.6

2.0

g/l

1.5

1.4

1.69

308

1744

(3000093) Morphology [Interpretation] in Blood Narrative

393

1.41

2.25

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

349

1.43

2.22

2.1

1.7

—

0.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

212

1.56

2.21

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

268

1508

1.20

2.20

3.2

3.4

u/ml

608.9

820.2

0.18

225

1304

(3028717) Thiamine [Mass/volume] in Blood

2.42

2.19

1.0

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

191

1.59

2.19

1.1

1.2

iu/ml

2.7

4.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

659

0.70

2.19

1.4

1.7

mmol/l

7.7

7.4

0.33

368

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

139

1.70

2.19

1.1

ng/l

161.7

1035.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

289

1.47

2.18

1.3

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

289

1.47

2.18

1.3

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

289

1.47

2.18

1.3

1.8

—

(3030313) Adrenal Ab [Titer] in Serum

2.51

2.18

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.51

2.18

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.94

2.16

1.2

1.3

pmol/l

327.6

574.1

0.56

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

176

1.61

2.16

1.4

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

176

1.61

2.16

1.4

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

176

1.61

2.16

1.4

2.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.25

2.16

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.25

2.16

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

130

1126

0.78

2.15

4.3

7.6

iu/ml

793.9

950.5

0.10

215

(21494890) Protein electrophoresis panel - 24 hour Urine

357

1.42

2.15

2.1

1.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

162

1366

0.80

2.14

4.9

3.9

—

(3016502) Oxygen saturation in Arterial blood

671

4058

1.12

2.14

6.7

8.3

95.4

95.5

0.04

644

3892

(4027681)

230

1.53

2.14

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

177

1.60

2.12

1.4

2.2

—

(3044927) Protein electrophoresis panel - Urine

319

1.44

2.11

1.4

1.2

—

(3016038) Potassium [Moles/volume] in Urine

275

1.47

2.10

1.2

1.1

mmol/l

37.6

33.4

0.74

245

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.62

2.07

1.0

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

5.62

2.07

1.0

—

(3023419) Bacteria identified in Sputum by Culture

480

1.35

2.07

2.4

2.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

116

1.75

2.07

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.20

2.07

1.0

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.97

2.06

1.1

1.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.04

2.06

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

166

896

1.25

2.05

1.5

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

260

1.48

2.05

2.3

2.8

e6/l

608.3

494.5

0.67

217

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.65

2.04

1.0

1.1

umol/24h

1.8

1.5

0.54

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

163

1.62

2.04

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1062

7751

0.91

2.00

4.0

22.3

22.0

0.23

466

3898

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

738

0.74

1.96

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

397

0.64

1.95

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

1.95

0.0

5.3

—

429.9

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

376

1.38

1.94

2.2

3.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.05

1.93

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

4.05

1.93

1.0

5.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

782

0.75

1.93

2.7

2.6

—

(3037756) Immunofixation for Serum or Plasma

149

801

1.26

1.92

1.7

1.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

625

3792

1.12

1.92

7.2

8.7

g/l

120.3

119.0

0.82

604

3638

(3015183) Erythrocyte sedimentation rate

130

1.66

1.88

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

221

1.50

1.88

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.86

1.8

2.1

umol/l

15.2

17.1

0.37

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.38

1.84

1.1

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

1.67

1.82

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

151

0.45

1.81

2.1

1.5

0.5

2.6

—

129

(3032773) Endomysium IgG Ab [Titer] in Serum

330

1.39

1.80

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.01

1.79

2.8

2.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.78

1.79

1.0

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.11

1.78

1.6

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.11

1.78

1.1

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

280

1.42

1.77

1.3

—

(3011648) Oxygen content in Venous blood

337

1.38

1.77

1.7

2.9

10.7

10.9

0.14

337

(3033705) Calcium.ionized [Moles/volume] in Venous blood

616

0.73

1.76

2.4

2.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.84

1.75

1.3

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.84

1.75

1.1

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

247

1.45

1.75

1.4

1.6

u/l

6.8

7.7

0.13

119

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

386

2289

1.14

1.73

8.2

10.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

146

795

1.24

1.72

2.7

3.4

u/ml

114.6

1218.9

0.78

134

720

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.93

1.71

1.3

—

(3035285) Chloride [Moles/volume] in Venous blood

620

0.74

1.70

2.4

2.3

mmol/l

104.8

105.3

0.38

613

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

174

0.50

1.70

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

619

0.74

1.68

2.4

2.3

mmol/l

4.0

4.1

0.85

612

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

170

944

1.22

1.68

1.4

1.7

—

(3002032) Base excess in Venous blood by calculation

658

4038

1.11

1.67

4.3

5.2

mmol/l

1.9

1.7

0.68

559

3313

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

189

1.50

1.66

1.1

1.2

u/ml

5.6

11.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.70

1.66

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.77

1.63

1.2

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

127

687

1.25

1.61

1.5

1.7

—

(3007463) Buprenorphine [Presence] in Urine

3.75

1.58

2.6

3.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

186

1.49

1.57

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

398

1.32

1.55

2.2

2.5

e9/l

1.5

1.1

2.38

256

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.78

1.55

1.6

1.2

—

(40768795) Lymph node Pathology biopsy report

375

1.33

1.54

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

235

1843

0.86

1.54

4.8

5.2

0.9

0.16

217

1743

(3021447) Carbon dioxide [Partial pressure] in Venous blood

659

4064

1.10

1.54

4.3

5.1

kpa

5.9

5.8

1.85

633

3939

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.71

1.53

3.8

2.4

ng/l

84.8

88.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.09

1.52

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

413

0.70

1.51

3.4

3.1

mg/l

41.2

67.6

0.47

295

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

307

1.36

1.51

2.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

163

914

1.21

1.49

2.5

3.3

kpa

8.1

8.2

0.13

146

858

(3034426) Prothrombin time (PT)

161

1.51

1.49

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

279

1.38

1.49

2.0

3.0

e6/l

979.3

560.4

2.15

110

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

174

0.54

1.48

1.9

1.5

63.6

66.0

0.11

141

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

145

1.54

1.48

2.6

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.69

1.48

1.4

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

113

1.61

1.47

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.71

1.47

1.1

1.9

ng/l

77.8

166.2

2.98

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

163

916

1.20

1.47

1.4

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

101

539

1.27

1.46

1.3

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.78

1.46

1.1

—

(3037121) Protein [Mass/volume] in Urine

226

1308

1.17

1.46

3.0

3.8

g/l

0.3

0.4

1.08

100

652

(40765096) Chromosome analysis panel by Banding

1.65

1.44

1.1

1.2

—

(3045142) Bone marrow Pathology biopsy report

445

1.29

1.43

1.3

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

173

981

1.19

1.42

1.9

2.5

g/l

129.4

126.8

0.68

123

773

(3022689) Creatine [Moles/volume] in Urine

125

1.57

1.42

1.8

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

225

1.41

1.40

5.4

6.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

271

1.37

1.40

1.7

1.3

promille

0.9

0.05

208

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

264

1554

1.15

1.38

1.4

1.3

miu/ml

199.9

238.1

1.03

129

711

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

240

1859

0.87

1.36

4.7

5.1

1.7

1.6

0.60

220

1756

(46235355) HIV 1 and 2 tests - Meaningful Use set

1609

10327

1.06

1.36

1.8

2.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.87

1.35

1.3

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.07

1.34

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

171

1.46

1.34

5.9

9.0

u/ml

43.4

13533.4

—

(3012565) Volume of 24 hour Urine

188

1.44

1.33

2.5

2007.4

1796.9

0.77

166

(3015235) Bicarbonate [Moles/volume] in Capillary blood

185

1064

1.18

1.32

2.8

3.3

mmol/l

25.4

24.5

2.14

156

951

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.71

1.30

1.5

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

339

2557

0.89

1.30

5.3

7.5

mmol/l

24.6

24.5

0.20

316

2386

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.89

1.29

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

614

0.78

1.28

1.6

1.5

g/l

32.9

30.7

0.75

540

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

184

1.43

1.28

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

184

1.43

1.28

1.4

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.06

1.27

1.0

1.1

u/ml

0.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

2.53

1.26

1.2

1.7

2.2

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

540

1.24

1.23

1.3

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.81

1.23

1.0

1.7

umol/24h

268.4

380.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.81

1.23

1.0

1.1

u/ml

0.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.65

1.21

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

1.19

0.0

3.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.01

1.19

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.16

1.19

1.6

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

168

969

1.17

1.18

1.2

1.3

—

(40768800) Prostate Pathology biopsy report

644

0.79

1.18

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.18

0.0

4.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.74

1.18

4.8

5.1

u/l

37.5

82.8

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.63

1.16

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

176

1021

1.17

1.16

1.3

ug/l

4.9

3.8

0.18

159

943

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

258

0.68

1.15

2.5

2.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

305

1.31

1.14

1.5

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

532

3303

1.09

1.14

4.0

3.9

kpa

4.5

4.7

0.94

507

3194

(3000919) Neutrophils/100 leukocytes in Pleural fluid

134

0.55

1.14

2.2

1.5

20.4

19.2

0.06

122

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

150

1.44

1.11

2.6

3.4

mg/l

8.1

8.0

0.04

120

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.78

1.11

1.7

2.6

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.78

1.11

2.7

1.8

mmol/l

6.8

8.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

469

1.24

1.10

1.3

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

231

0.67

1.09

3.7

8.0

mg/l

49.1

878.1

0.55

179

(40768441) Liver Pathology biopsy report

278

1.31

1.09

1.6

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

229

1746

0.88

1.09

1.9

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.79

1.05

1.0

u/ml

0.0

0.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

536

0.79

1.05

1.5

e6/l

2453.4

1656.9

0.37

374

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

263

1.31

1.03

1.0

1.2

ratio

1.1

0.32

105

(3018572) Chloride [Moles/volume] in Blood

119

947

0.85

1.03

5.4

7.1

mmol/l

104.2

105.0

0.82

103

859

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.58

1.02

1.2

1.1

—

(3039000) Anion gap in Blood

119

946

0.85

1.02

5.4

7.1

mmol/l

11.5

11.2

0.39

103

858

(3014148) Varicella zoster virus Ab [Titer] in Serum

726

0.82

1.01

1.3

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

108

0.56

1.01

5.4

12.4

—

(3051101) Glucose [Moles/volume] in Cord blood

109

0.56

1.01

4.9

5.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.05

1.00

1.1

u/l

11.1

6.7

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.05

1.00

1.1

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.80

0.99

1.0

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.99

0.0

4.0

—

49.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.76

0.93

1.5

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

475

0.79

0.93

1.5

1.4

e6/l

29702.2

29936.1

0.01

261

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.48

0.92

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.52

0.92

1.1

1.3

—

(21494434) Karyotype in Bone marrow

341

1.25

0.90

1.2

—

(44806420)

149

0.63

0.90

1.6

2.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.13

0.90

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.53

0.90

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

519

1.20

0.90

2.3

2.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

124

0.60

0.90

4.9

11.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

246

1.29

0.88

1.4

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.72

0.88

1.1

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

188

0.68

0.88

1.9

2.0

e6/l

474.5

718.0

0.60

133

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

373

0.78

0.87

1.2

1.3

—

(3012441) Differential panel - Pleural fluid

462

0.80

0.86

1.6

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

171

0.67

0.85

1.9

1.8

e6/l

1865.3

12815.1

—

(3047181) Lactate [Moles/volume] in Blood

177

1342

0.89

0.83

4.8

6.2

mmol/l

1.3

0.22

151

1186

(44806071)

1.69

0.83

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.69

0.83

1.2

1.1

—

(3045788) Cell count panel - Pleural fluid

422

0.80

0.82

1.6

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.74

0.81

1.1

1.3

—

(4212803)

1.74

0.81

1.1

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.81

0.0

4.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.81

1.3

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

250

1.27

0.80

1.4

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

634

4030

1.07

0.80

4.9

11.0

mmol/l

9.0

10.8

8.98

599

3872

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.50

0.80

1.0

1.2

—

(4198724)

173

1.33

0.80

2.3

1.7

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.79

0.0

1.3

—

20.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.55

0.79

1.0

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

317

1.24

0.79

1.9

2.0

13.5

14.9

0.37

134

(3046861) Legionella sp Ag [Presence] in Urine

1.84

0.78

1.2

—

(3001729) Color of Synovial fluid

1.84

0.78

1.7

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.46

0.75

1.8

1.5

ug/l

8.7

9.7

0.40

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

393

1.20

0.75

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.69

0.75

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.11

0.75

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.11

0.75

1.2

1.1

u/field

0.8

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

140

1.35

0.74

1.1

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.64

0.73

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

315

1.22

0.72

1.3

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.60

0.71

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.69

0.70

1.0

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

154

926

1.12

0.70

1.2

1.4

u/ml

323.7

279.7

0.92

107

648

(3035880) pH of Pleural fluid

255

0.77

0.69

1.6

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.42

0.69

1.3

1.1

—

(4281824)

529

1.16

0.68

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

736

0.87

0.66

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

203

1.26

0.66

1.1

1.2

u/l

17.3

29.6

1.49

157

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

117

695

1.14

0.66

1.3

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

104

613

1.15

0.65

3.3

2.2

13.2

13.1

0.43

104

598

(37021550) Renin [Units/volume] in Plasma --upright

1.46

0.65

1.2

1.4

mu/l

136.4

90.5

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

138

1.32

0.64

2.1

2.8

au/ml

50.6

79.8

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

204

1.26

0.64

1.1

1.2

u/l

75.8

90.2

0.87

159

(21494815) CD4 cells/100 lymphocytes in Specimen

376

1.18

0.64

1.8

2.2

45.7

39.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

115

1.35

0.63

2.7

3.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

147

889

1.12

0.63

1.8

2.8

nmol/l

0.8

0.31

124

744

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.30

0.62

1.3

1.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.61

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.61

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.61

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.61

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.61

0.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

218

1.24

0.60

4.4

15.8

—

(3013862) HLA-DP [Type]

0.00

0.60

0.0

1.0

—

(3019174) dRVVT (LA screen)

1.54

0.59

1.0

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

367

0.83

0.59

2.0

u/field

1.4

2.0

0.61

117

(40757494) Bilirubin.total [Moles/volume] in Blood

188

0.75

0.59

2.0

2.3

umol/l

13.9

23.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

101

600

1.14

0.59

1.5

1.2

u/l

25.2

49.3

1.91

510

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

126

0.70

0.59

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.57

0.56

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.40

0.55

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.40

0.55

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.40

0.55

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.40

0.55

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.51

0.54

1.5

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.35

0.54

1.1

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

382

2728

0.94

0.53

4.6

4.0

g/l

128.8

125.9

1.81

371

2671

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

149

1.27

0.53

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.53

0.52

2.3

2.4

u/field

0.9

0.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

223

1.21

0.51

1.0

ng/l

381.8

335.8

0.36

155

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

0.74

0.50

1.9

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

137

0.74

0.50

1.9

2.6

—

(3048879) Bone marrow aspiration report

1.35

0.49

1.5

2.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

157

1.25

0.49

2.6

3.2

52.7

56.1

0.52

150

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

176

1.23

0.47

1.3

1.4

pmol/l

79.5

52.7

0.43

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.48

0.47

1.0

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.48

0.47

1.1

1.4

—

(3044007) Cell count panel - Peritoneal fluid

143

0.75

0.47

1.9

2.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

542

1.12

0.46

9.4

6.9

mg/l

11.6

11.8

0.13

500

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

295

1.17

0.46

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

172

1072

1.08

0.45

1.3

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

106

790

0.90

0.45

1.3

1.5

mmol/l

7.0

6.9

0.08

541

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

209

0.81

0.45

1.0

1.1

miu/ml

1989.5

1524.3

1.23

209

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

726

0.90

0.45

1.1

iu/ml

22.6

645.4

0.63

145

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

227

1.19

0.44

1.0

ng/l

658.8

723.8

0.50

154

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

227

1.19

0.44

1.0

ng/l

47.5

45.1

0.12

157

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

147

1.24

0.44

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

230

1656

0.93

0.44

2.0

ug/l

2.1

2.4

0.17

204

1480

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.69

0.44

1.0

mmol/l

8.1

8.5

—

(4133840)

1.35

0.44

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

209

1.19

0.43

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

209

1.19

0.43

1.3

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.61

0.43

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.43

14.0

8.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

310

0.85

0.43

1.5

1.3

u/l

11.8

13.4

0.28

276

(3010937) Rubella virus Ab [Presence] in Serum

1.42

0.43

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

169

1057

1.08

0.42

1.3

1.7

—

15.0

—

(3033799) Differential panel - Peritoneal fluid

155

0.78

0.42

1.4

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.53

0.42

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.53

0.42

1.2

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.41

0.0

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.8

—

9.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.35

0.41

1.6

1.4

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.0

—

0.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.40

0.0

1.0

—

0.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.44

0.40

3.3

2.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.66

0.40

4.6

8.2

—

(3019060) Gas panel - Arterial blood

400

2581

1.05

0.38

3.4

5.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.50

0.37

1.2

1.1

—

142.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.50

0.37

1.2

1.0

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

1.50

0.37

1.8

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

135

982

0.93

0.37

1.6

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

426

0.89

0.36

1.3

1.9

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.45

0.36

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.45

0.36

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.36

1.2

1.0

—

(3020650) Glucose [Presence] in Urine

1.27

0.36

1.2

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.75

0.36

2.5

2.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.40

0.35

3.3

6.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.35

0.34

1.0

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

209

1.16

0.34

2.0

1.8

u/field

1.0

4.2

1.81

145

(40765089) Chromosome analysis panel - Blood by G-banded

179

0.83

0.33

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

203

1.16

0.33

1.1

1.3

—

(3045716) Anion gap in Serum or Plasma

186

0.83

0.33

5.4

2.4

mmol/l

9.5

8.8

0.41

132

(3022475) Manganese [Moles/volume] in Blood

1.39

0.32

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

499

0.90

0.32

1.3

1.4

mmol/l

8.2

11.0

2.24

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

505

1.10

0.32

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

159

1141

0.94

0.32

3.1

4.9

mmol/l

3.9

0.44

154

1064

(3044009) aPTT.lupus sensitive (LA screen)

1.28

0.30

1.0

1.2

—

(3000012) Reticulocyte production index

244

1.13

0.29

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

147

0.83

0.29

1.7

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.28

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.25

0.28

1.5

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

213

1.14

0.28

1.3

1.5

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.28

0.27

1.7

1.5

—

(3021901) Oxygen saturation in Capillary blood

126

797

1.07

0.27

2.6

3.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

589

1.08

0.26

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.67

0.26

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.23

0.26

12.4

6.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.21

0.25

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1.13

0.25

1.3

1.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.74

0.24

1.0

1.2

u/l

19.8

22.0

—

(40768806) Pleura Pathology biopsy report

462

0.92

0.24

1.7

1.6

—

(3017704) Immunofixation for Urine

229

1.12

0.24

1.7

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.24

1.0

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

146

1037

0.95

0.23

2.1

2.7

ug/min

49.9

100.8

2.13

663

(3026692) Albumin [Mass/volume] in Peritoneal fluid

136

0.84

0.23

1.1

1.4

g/l

14.3

14.2

0.01

112

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

114

0.83

0.23

1.1

1.3

—

(40758292) HTLV I+II Ab panel - Serum

1.25

0.22

1.7

1.4

—

(44806118)

470

1.08

0.22

1.4

1.6

—

(44790048)

470

1.08

0.22

1.4

1.6

—

(44790047)

470

1.08

0.22

1.4

1.6

—

(44790049)

470

1.08

0.22

1.4

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.25

0.22

1.6

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

321

1.09

0.22

1.7

1.5

u/l

13.0

0.02

307

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.22

0.0

1.3

—

3.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.27

0.22

4.2

2.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

250

1.11

0.22

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.81

0.21

1.3

2.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.16

0.19

1.5

2.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

140

987

0.96

0.19

3.4

3.3

nmol/l

0.8

0.14

105

769

(3020891) Body temperature

216

1506

0.97

0.18

3.7

5.5

—

(3012898) Urea [Moles/volume] in Urine

0.73

0.17

1.2

1.1

mmol/l

146.4

102.6

—

(40757373) Influenza virus identified in Isolate

124

0.87

0.16

1.1

1.5

—

(3017509) Phencyclidine [Presence] in Urine

1.12

0.16

1.0

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

223

1.09

0.15

3.2

3.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

210

1.09

0.15

1.7

3.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

200

0.91

0.14

1.8

1.6

nmol/l

1.2

1.1

0.11

162

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.84

0.14

1.0

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

115

0.88

0.13

1.7

1.3

ug/l

1327.0

49.2

—

(3000330) Specific gravity of Urine by Test strip

361

2387

1.02

0.13

3.6

3.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

292

1.06

0.12

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1348

9018

1.01

0.11

1.6

1.8

—

(3003694) ABO and Rh group [Type] in Blood

2094

14037

1.01

0.11

1.5

1.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

169

1.08

0.10

1.4

2.1

u/ml

1200.0

56591.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.09

0.09

2.6

2.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

354

1.05

0.09

1.3

1.2

nmol/l

1.7

1.4

1.11

319

(3041806) Other cells [#/volume] in Blood by Manual count

223

1.06

0.08

1.6

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

296

1967

1.02

0.08

4.4

3.4

0.6

0.7

0.81

289

1906

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

151

1.07

0.08

1.6

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.10

0.07

1.5

2.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.08

0.07

1.9

2.4

mg/l

24.1

21.6

—

(3000285) Sodium [Moles/volume] in Blood

0.86

0.07

1.0

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

178

1.06

0.07

1.0

1.1

93.6

91.7

0.17

144

(3044242) Glucose [Moles/volume] in Arterial blood

193

0.94

0.07

1.3

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

444

1.03

0.07

1.5

1.4

nmol/l

27.8

33.6

1.13

418

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

153

1012

1.02

0.07

1.3

1.7

u/ml

115.6

116.6

0.04

235

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

302

2014

1.01

0.06

4.4

3.5

1.3

1.2

1.14

302

2002

(4034850)

199

1360

0.99

0.05

8.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

247

1685

0.99

0.05

3.5

u/ml

0.4

0.3

0.07

135

961

(3004451) EKG impression Narrative

187

1.05

0.04

1.3

1.2

—

(3014891) Appearance of Pleural fluid

0.91

0.04

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

255

1.03

0.03

2.1

2.9

45.2

37.5

0.93

(3051387) C reactive protein [Mass/volume] in Capillary blood

141

960

0.99

0.02

4.3

2.7

mg/l

25.5

30.0

0.78

629

(3040151) Glucose [Moles/volume] in Capillary blood

520

0.99

0.02

2.9

24.0

mmol/l

8.5

7.4

0.28

434

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

309

0.98

0.01

1.5

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

251

1.02

0.01

1.3

1.5

—

(3017569) Oxygen content in Arterial blood

187

0.97

0.01

1.5

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

196

1328

1.00

0.01

2.4

4.1

mg/l

1.4

1.7

9.45

179

1226

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

803

5408

1.00

0.00

3.0

2.8

ug/l

0.7

0.9

4.11

539

3704

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

200

1.01

0.00

3.1

3.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

304

1.00

0.00

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

178

0.98

0.00

1.7

1.9

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

275

1.01

0.00

1.6

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.97

0.00

1.4

2.0

ug/l

1.8

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.04

0.00

1.0

1.2

—

(3019977) pH of Arterial blood

228

1.01

0.00

1.8

2.8

7.4

0.00

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.98

0.00

2.0

2.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

2.2

—

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.94

0.00

2.6

2.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

37.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

82.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.96

0.00

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

(3032641) Amino acids panel - Urine

0.00

0.0

2.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.96

0.00

1.3

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_FENAMATES – Fenamates

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fenamates

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Fenamates (RX_FENAMATES)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints